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Abstract 
 
     Forkhead box (FOX) proteins are transcription factors that play a significant role during 
embryonic development and throughout adulthood with functions in regulating cell 
differentiation, proliferation, and apoptosis. Consequently, mutated or unregulated FOX proteins 
have been linked with numerous human genetic diseases.  Recently, a deletion of five residues 
(GIPFL) in the C-terminal domain of the FOXL1 protein has been linked to another human genetic 
disease. This manuscript presents attempts to determine the three-dimensional structure of the 
C-terminal domain of FOXL1 protein, both with the mutation (FOXL1MUT) and without (FOXL1CTERM), 
in order to uncover the structural features that prevent the proper functioning of the mutant. This 
structural information was obtained using both computational and experimental methods. 
Computationally, coarse-grain molecular dynamic (MD) simulations were performed using replica 
exchange MD to provide a prediction of the folded structure. Experimentally, the C-terminal 
domain of FOXL1 and its mutant was expressed, enriched, and then structurally characterized 
using circular dichroism.   
     Bioinformatics analysis of FOXL1 revealed that the mutation occurred in the most ordered and 
evolutionary-conserved portion of the C-terminal domain of FOXL1, suggesting that this mutation 
could severely affect the structure and function of FOXL1CTERM.  This is in agreement with the replica 
exchange molecular dynamics simulations results, which predicted that FOXL1CTERM was more 
folded and structured than FOXL1MUT. Moreover, the simulations showed that the mutation in the 
FOXL1MUT system disrupted its structure and hydrophobic core, causing the mutant to have an 
increased amount of randomly coiled structure. The computational results are supported by 
preliminary experimental data. Circular dichroism results indicated that FOXL1CTERM has a 
predominantly helical structure while FOXL1MUT was partially helical with some randomly coiled 
regions.  
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Chapter 1  
Introduction  
1.1. Protein Structure and Function 
     Proteins are large biomolecules which serve many vital roles in all living organisms, including 
catalyzing reactions, replicating DNA, and transporting molecules from one location to another.1 A 
protein is composed of one or more chains of amino acid residues that fold into complex three-
dimensional structures. The amino acid sequence of a protein ultimately determines its three-
dimensional structure.1 Since the proper functioning of proteins is greatly dependent on their 
structure, a mutation in the amino acid sequence can cause the protein to fold incorrectly and lead 
to severe human diseases.2–4 
     Determining structural information about proteins and their mutants can yield insight into 
their function or misfunction.1,3 The configuration of a protein can be classified by its primary, 
secondary, and tertiary structure, as shown in Figure 1.1. The primary structure is the sequence 
of amino acids that constitute the protein. The secondary structure is the local shape of a portion 
of the protein brought about though hydrogen bonding between the amide groups of the protein 
backbone. The major secondary structure motifs include 𝛼-helices (coil-shape) and β-sheets. The 
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tertiary structure is the overall three-dimensional structure that results from protein folding such 
that contacts are formed by the secondary structural elements. Additionally, if a protein is 
composed of multiple folded polypeptide chains, it can further be classified by its quaternary 
structure. The quaternary structure is the number and arrangement of the polypeptide subunits 
with respect to each other.          
     Proteins, such as those investigated in this thesis (see Section 3.1.1 below), do not necessarily 
need to have a unique, ordered structure to perform a function. There are numerous intrinsically 
disordered proteins (IDPs) that lack well-defined three-dimensional shape under physiological 
conditions and still perform biologically relevant functions.5,6 These IDPs can be fully disordered 
or possess local regions of disorder referred to as intrinsically disordered regions (IDRs).6   
     In general, IDPs and IDRs are often characterized by low-complexity sequences, which have 
little diversity in the amino acid composition and are generally made up of just a few different 
amino acids. In particular, IDPs and IDRs are mainly composed of polar and charged amino acids 
(e.g. arginine (R), lysine (K), glutamate (E), proline (P), and serine (S)), while having low levels of 
bulky hydrophobic amino acids (e.g. tryptophan (W), tyrosine (Y), isoleucine (I), and valine (V)).5 
IDPs generally carry out their function by binding to a target molecule, often another protein, and 
fold into a defined structure upon binding.5  
 
    
Figure 1.1: Main protein structure levels. Figure adapted from “Main protein structure levels” 
by Mariana Ruiz Villarreal which was released into the public domain in 2008, and “Ribbon 
diagram of a protein” by David E. Volk which was released into the public domain in 2007.  
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1.2. FOXL1 Protein  
     The forkhead box (FOX) class of proteins exhibit important structure-function relationships 
that are essential to human health.3,4 FOX proteins have a structured N-terminal domain, known 
as the “forkhead” domain, that binds to DNA in order to regulate transcription.3,4,7 Through 
transcriptional regulation, FOX proteins influence a diverse range of cellular and developmental 
processes.4,8–13 Considering their crucial functions in humans, it is not surprising that mutated or 
unregulated FOX proteins have caused human genetic diseases that can surface during embryonic 
development and throughout the lifetime of an adult.3 As of 2003, mutations in 11 FOX proteins 
have been linked to human genetic diseases.3 Premature ovarian failure, mental retardation, and 
severe immune defects are just a few of the severe health problems linked with mutations in the 
FOXO3a, FOXP1, and FOXN1 proteins, respectively. Recently, a mutation in FOXL1 protein has 
been shown by Dr. Terry Young† and coworkers to be associated with a human genetic disease 
(unpublished). Thus, the structure of FOXL1 and the effect of this mutation on its structure is of 
high interest.  
     The tertiary structure of the N-terminal DNA binding domain is similar for all forkhead box 
proteins, including FOXL1. The structure of the forkhead domain was determined experimentally 
by nuclear magnetic resonance for FoxC2‡.14 This forkhead domain is composed of approximately 
80 to 100 amino acids3,15 which forms three α-helices, three β-strands, and two wing-shaped 
loops, as seen for FoxC2 in Figure 1.2. A loop is a section of amino acids that does not have fixed 
internal hydrogen bonding, which is often seen connecting regular secondary structural elements. 
The forkhead motif has been referred to as a winged helix in the literature because the loops have 
a butterfly-like appearance.16  The alignment of the N-terminal structure with the amino acid 
sequence of FOXL114 is shown in Figure 1.3.      
     In contrast to the N-terminal domain, the C-terminal region of forkhead proteins are highly 
divergent, leading to a variety of classes of forkhead box proteins that each have a different C-
terminal structure and function.15 In fact, more than one hundred members of the forkhead gene 
                                                             
† Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, Canada 
‡ Forkhead box nomenclature contains all uppercase letters for humans (FOXL1), only the first letter 
capitalized for mice (Foxl1), and the first and subclass letter capitalized for all other chordates (FoxC2).15  
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family have been identified. In particular, humans have 50 FOX genes which code for 50 FOX 
proteins, one of which is FOXL1.3 Due to the overwhelming number of forkhead proteins, the 
tertiary structure of the C-terminal region of most of these proteins have not been characterized, 
including FOXL1.  
     FOXL1 is a 345 amino acid protein with three known functions.16–19 First, it is a transcription 
factor required for proper proliferation and differentiation in the gastrointestinal epithelium.10–12 
Secondly, in the Wnt/β-catenin pathway, the FOXL1 protein is involved in the inhibition of Wnt 
signalling.12 Finally, in the Sonic-Hedgehog signalling pathway, the FOXL1 protein is involved in 
mediation of endoderm-mesoderm signals.8  
     The 345 amino acid sequence of FOXL1 is detailed in Figure 1.3. The well-studied N-terminal 
forkhead domain spans residue 48-139. This domain is composed of three α-helices (54-63; 72-
83; 92-99), three β-strands (68-70; 107-112; 120-125), and two wing-shaped loops (113-119; 126-
140) structural elements. The mutation in FOXL1 under investigation here corresponds to the 
deletion of five amino acids involving residues 326-330, which is highlighted in red. The deleted 
sequence consists of a glycine (G), isoleucine (I), proline (P), phenylalanine (F), and leucine (L), 
which this thesis refers to as the GIPFL deletion.  
 
Figure 1.2: The structure of the forkhead domain of FoxC2 (UniProt ID Q99958) has three α-
helices (purple spirals), three β-strands (yellow arrows), and two wing-shaped loops (labelled 
W1 and W2). The blue and black spheres marks the N- and C-terminus, respectively. The 
coordinate file was downloaded from the PDB website§ (PDB ID 1D5V) and rendered using VMD 
1.9.1.  
                                                             
§ http://www.rcsb.org/pdb/home/home.do 
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       The GIPFL deletion occurs in the C-terminal region of FOXL1, which has not yet been 
structurally characterized. Unfortunately, it is difficult to study the full 345 amino acid FOXL1 
protein both computationally and experimentally. A large protein system is computationally 
demanding because it requires long simulation times to sample the conformational space. It is 
also experimentally challenging to elucidate the structures of large proteins using spectroscopic 
techniques like NMR because they often contain a large quantity of signals in the spectrum. Thus, 
this thesis will investigate only the C-terminal domain of FOXL1. A domain is a section of a protein 
that can maintain its structure and function independently of the rest of the protein chain. Here, 
the C-terminal domain is defined as the sixty-nine most C-terminal residues of FOXL1, which we 
refer to as FOXL1CTERM. The details of how the C-terminal domain was determined can be found 
in Section 3.1.1. The mutant of C-terminal FOXL1 protein, which we refer to as FOXL1MUT, is 
defined here as the same residues as FOXL1CTERM with the GIPFL deletion.  
 
 
Figure 1.3: The FOXL1 protein sequence is composed of 345 amino acids. FOXL1 has a 
characterized N-terminal DNA binding domain spanning residue 48-139, which is made up of 
three α-helices (54-63; 72-83; 92-99), three β-sheets (68-70; 107-112; 120-125), and two wing-
shaped loops (113-119; 126-140) structural elements. The mutant FOXL1 has five deleted amino 
acids residues 326-330 (GIPFL), which are highlighted in red. The structures studied in this thesis 
are FOXL1CTERM (highlighted with green and red) and FOXL1MUT (highlighted in green). 
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     The goal of this research is to determine the structure of FOXL1CTERM and FOXL1MUT in order to 
gain insight into the structural differences that causes the loss of function in the FOXL1 mutant. 
In this thesis, both computational and experimental methods are used in an attempt to determine 
the structure FOXL1CTERM and FOXL1MUT.  
1.3. Methods to Predict Protein Structure 
1.3.1. Introduction 
     Several popular methods that are employed to predict protein structure include 
bioinformatics,6,20,21  homology modelling,22,23 and molecular simulations.24–27 These methods all 
require the amino acid sequence of the protein in order to make predictions of the protein 
structure. The full FOXL1 sequence can be found on the UniProt database using the identification 
Q12952.** The information acquired from these methods can be very valuable in predicting 
protein disorder, secondary structure, sequence conservation, and even tertiary structure.  The 
method of choice largely depends on the protein studied and whether or not structural 
information is available on other proteins with similar amino acid sequences. 
1.3.2. Bioinformatics 
     The first step in investigating protein structure should involve employing bioinformatics to 
predict the properties and structure of the protein. Structural bioinformatics is the field of 
computational biology that infers the properties and structure of macromolecules based on 
generalizations made from experimentally and computationally solved structures. 
 Bioinformatics tools are often freely available online and provide a quick, cheap, and easy 
method to gain insight into the properties of a protein. In the following sections, several 
bioinformatics tools are discussed, which are later utilized on FOXL1 to determine intrinsically 
disordered regions,6 identify domains, predict secondary structure,28 and perform sequence 
alignment.20   
                                                             
** http://www.uniprot.org/uniprot/Q12952 
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1.3.2.1. Protein Disorder 
     A protein disorder predictor computationally deduces the ordered and intrinsically disordered 
regions of a protein.5 Intrinsically disordered regions (IDRs) are partial regions of proteins which 
lack stable and well defined three-dimensional structure.6  
     There are numerous protein disorder software packages freely available. These predictors 
differ in the input required as well as the predictive approach used to assign disorder. The 
predictor may require as input either amino acid sequence, sequence complexity, amino acid 
composition, position specific scoring matrices, predicted secondary structure, or predicted 
accessible surface area.6 These methods use a variety of algorithms to estimate the levels of 
protein disorder, including artificial neural networks, super vector machines, Baysesian methods, 
decision tree bases methods, template sequences, or charge-hydropathy plots.6  
     In this thesis, PONDR-FIT was selected to predict the structured and unstructured regions of 
FOXL1 because of the numerous advantages associated with using this disorder program.6 First, 
PONDR-FIT only requires the amino acid sequence as input, which is readily available for FOXL1. 
In addition, PONDR-FIT is a meta-predictor, meaning it combines six individual disorder predictors 
(PONDR-VLXT, PONDR-VSL2, PONDR-VL3, FoldIndex, IUPred, and TopIDP) to create an eight-fold 
cross-validation disorder predictor. The benefit of combining these six individual predictors is that 
each uses a different predictive approach, and thus helps emphasize different features of the 
sequence. Xue et. al., the developers of PONDR-FIT, showed that combining these six predicators 
improves the accuracy between 3-20% compared to the individual intrinsic disorder predictors.6 
They further demonstrated that PONDR-FIT was more accurate than each of the individual 
predictors across all datasets studied including fully ordered, fully disordered, and partially 
disordered datasets.6 This is important for this study because FOXL1 has a structured N-terminal 
DNA binding domain, but we do not know the state of the C-terminal region. Overall, PONDR-FIT 
has an estimated 85% prediction accuracy based on sensitivity for the disordered residues.6 
     However, like all protein predictors, PONDR-FIT has limitations. First, disorder predictors are 
not very accurate along the boundary between the structured and intrinsically disordered 
regions.6 Another drawback is that there is poor accuracy for disordered regions of ten residues 
or less.6  
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     The importance of protein disorder predictions is that they can provide insight into the 
existence of several domains within a protein. This has applications in reducing the size of the 
system studied. A disordered analysis was performed on FOXL1 to determine if the mutation 
occurs in a distinct domain of the protein. 
1.3.2.2. Sequence Alignment 
In bioinformatics, a sequence alignment of a protein is a way of arranging the amino acid 
sequence of two or more proteins in order to identify regions of similarity.29 The results of a 
sequence alignment can provide structural and sequence conservation information. This arises 
because proteins sharing similar sequences often have similar structural, functional, or 
evolutionary relationships. Moreover, the degree of similarity between proteins can be 
interpreted as a rough measure of how well a particular region is evolutionarily conserved.30 A 
more conserved region of a protein suggests that the region is structurally or functionally 
important. In reference to the study of FOXL1, a sequence alignment is important to find similar 
proteins with already known structures for homology modelling, as well as to identify conserved 
amino acids in the C-terminal domain. 
The Basic Local Alignment Search Tool for Proteins (BLASTP)20,23,29 is a free, online, heuristic 
sequence alignment program that finds regions of local similarity between the query protein and 
those in the protein data bank (PDB). To perform a sequence alignment, the BLASTP algorithm (1) 
compiles a list of “high scoring”, consecutive amino acid “words” from the query protein, (2) scans 
the database to find matches, and (3) extends the match to find the maximum segment pair 
alignment.20 To quantify the alignment, BLASTP employs a PAM-120 matrix31,32 of similarity scores 
to score all possible pairs of residues. In this matrix, identical pairs of residues have the highest 
positive score, conservative replacements (where the chemical properties of the amino acid stays 
the same) also have positive scores, while unlikely replacements have negative scores. 
There are numerous advantages and several limitations of using BLASTP.  First of all, the 
BLASTP algorithm is simple, robust, fast, and free.20 As well, BLASTP is of comparable sensitivity 
and an order of magnitude faster than other current heuristic sequence alignment approaches.20 
In addition, by nature of the local similarity algorithm, BLASTP can find distantly related proteins, 
such as those with a similar active site. However, since the local similarity algorithm depends on 
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aligning consecutive amino acids words, it can miss biologically similar sequences that have a 
global alignment but do not have many words in common.20 BLASTP may also overlook related 
proteins if the input sequence has a uniform pattern of conservation with few high scoring words. 
Finally, although BLASTP can find biologically significant relationships, a search can also result in 
chance similarities and it is left to the researcher to remove these irrelevant results.20  
A sequence alignment is a valuable tool to deduce structural and sequence conservation 
information. In reference to the study of FOXL1, a sequence alignment is important to identify 
conserved amino acids in the C-terminal domain, especially concerning the GIPFL residues. 
Furthermore, if similar proteins with already known structures are found, then structural 
information through homology modelling could be acquired.  
1.3.2.3. Secondary Structure Prediction 
     Several one-dimensional predictors have been created that use the protein sequence to 
predict its secondary structure.28,33 PredictProtein is an online server that encompasses numerous 
programs that perform sequence alignment, predict structure, and infer functions of proteins.33 
One utility found under the umbrella of the PredictProtein server is PROFsec:  a one-dimensional 
predictor of secondary structure.28 To construct a structure prediction, PROFsec takes the amino 
acid sequence as input, and then employs evolutionary information generated by a multiple 
sequence alignment and feeds this alignment into a neural network system.28 After multi-level 
processing to obtain one-dimensional information and filtering to remove drastic, unrealistic 
predictions, PROFsec outputs a probable secondary structure for each amino acid in the protein. 
Each amino acid is labelled as one of three secondary structure states encompassing helix (H = α, 
π, or 310), extended strand (E = parallel or anti-parallel β-sheet), and loop (L).28 
     Although several secondary structure predictors exist, PROFsec was chosen because it has a 
high prediction accuracy of 72% ± 9%.33 However, the PROFsec program was trained on 
globular, water soluble proteins, and thus the projected accuracy is likely only valid for proteins 
of the same type.28 Another limitation of PROFsec is that the accuracy of the secondary structure 
prediction is highly dependent on the accuracy of the sequence alignment and the number of 
diverse alignments made.28 In fact, poor alignments have been shown to give poor secondary 
structure predictions, even for homologous proteins.28 In addition, rare folds are rejected by the 
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PROFsec algorithm, which leads to incorrect predictions for proteins that do possess these 
unusual structural features. One final limitation of PROFsec is that the predictor is less reliable 
along the ends (caps) of helices and strands as compared to the core.28 Thus, a predicted 
secondary structure segment can be longer or shorter than the true structure.  
     Secondary structure predictions are valuable tools that can make accurate predictions of 
protein secondary structure from the primary structure. In reference to the study of FOXL1, a 
structure prediction gives us a first look at the structural blueprint and can perhaps be used as a 
starting point for computer simulations.  
     Although bioinformatics provides a quick and easy way to deduce information about protein 
structure, it is not a replacement for an experimentally determined structure that provides the 
tertiary structure that is typically responsible for protein function. 
1.3.3. Homology Modeling  
     Homology modeling is a technique employed to model a “target” protein of unknown structure 
by comparing it to a homologous “template” protein of known 3D structure.22,23,30,34,35 This 
method assumes that proteins with similar amino acid sequences have similar structures.22,30 This 
assumption is well-supported for proteins found in nature: evolutionarily related proteins with 
50% sequence identity usually have near identical tertiary structures.30 However, this assumption 
does not extend to artificially similar proteins, or pseudohomologs, that are synthetically 
designed to have similar sequences with different structures.30    
     The homology modeling process involves (1) identifying the best template protein, (2) aligning 
the target to the template sequence, (3) building a three-dimensional model of the target protein 
from the alignment, and finally (4) evaluating the reliability of the model.23,30 There are numerous 
homology modeling programs available including Modeller, SegMod/ENCAD, SWISS-MODEL, 3D-
JIGSAW, nest, and Builder.22 In a benchmark study of these programs, it has been shown that no 
single program outperforms the others in all tests, including reliability, speed, structural accuracy, 
and physiochemical correctness.22 However, Modeller is currently the most popular because it is 
fast and free for academic use.22  
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     In the absence of an experimentally known structure, homology modelling can be a faster 
approach to elucidating protein structure.23 This technique can provide insight into structural and 
evolutionary features of a protein, and is useful in drug design efforts.22 Unfortunately, homology 
modelling is only practical if a suitable template protein exists. The accuracy of the generated 
structure greatly depends on the choice of template protein and the quality of the target-
template sequence alignment.22,23 Another problem is that it can be difficult to model the effects 
of mutations, because the mutant protein will often have the same template protein as its 
naturally occurring form.22 
       Homology modeling can provide a good starting point for predicting the tertiary structure of 
a protein. In fact, the structure generated from homology modelling can be further used in 
molecular dynamics simulations to make inferences about the kinetics and dynamics of the 
protein. 
1.3.4. Computational 
     Theoretical chemistry combines the laws of physics and chemistry with mathematical tools in 
order to rationalize chemical phenomena.36 This field has opened the doors to describe, explain, 
and predict the chemistry of molecules. Computational chemistry integrates theoretical 
chemistry with computer science in order to study, model, and simulate chemical systems.37 As 
computing power increases and efficient algorithms are designed, computational chemistry 
methods can deal with large biomolecular systems with better accuracy. There are numerous 
computational chemistry tools that range from highly accurate methods, which are derived from 
quantum mechanics such as ab initio and density functional methods,36 to highly approximate 
methods, which are based on classical descriptions of forces such as molecular mechanics.38–40 In 
order to determine the structure of an unknown protein, the less computationally expensive 
molecular mechanics approximations are generally employed and coupled with classical 
molecular dynamics simulations to fold a protein into its native structure.38   
1.3.4.1. Molecular Dynamic Simulations  
     Protein folding by molecular dynamics simulations explores the process by which a protein 
changes its conformational state during a trajectory to obtain a more stable, lower energy 
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structure.41 To fold a protein, computer simulations must first model the physical forces in 
chemical systems. The major factors that contribute to protein folding include hydrogen bonding, 
van der Waals interactions, backbone angle preferences, electrostatic interactions, hydrophobic 
interactions, and chain entropy.41 These physical forces can be described classically through a 
force field: a mathematical model used to approximate the potential energy of a system.24,25 In a 
computer simulation, a protein is placed in an initial unfolded configuration. By using a force field 
to determine the energy of the system (Equation 1.1) and employing dynamical laws of motion 
to propagate the position of the atoms through time by a series of times steps (𝛥𝑡) (i.e. the 
trajectory shown in Equation 1.2 and Equation 1.3), changes in the conformation of a protein can 
be modelled during the course of a simulation.41  
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 𝑭 = −𝛻𝑈 (1.2) 
 
 𝒓𝒊(𝑡 + 𝛥𝑡) = 2𝒓𝒊(t) − 𝒓𝒊(𝑡 − 𝛥𝑡) +
𝑭𝒊(𝑡)
𝑚𝑖
𝛥𝑡2 (1.3) 
     An important consideration prior to running a computer simulation is the resolution of the 
system and the chosen force field.42 In general, a particular force field is tied to a specific scheme 
for atomic representations. The force field chosen greatly affects the accuracy of the potential 
energy calculations and the molecular dynamics simulation, so this decision should be given 
significant consideration.  
    The highest resolution models in molecular mechanics are the all-atom models where each 
atom is represented as an interaction point.36,37 The potential energy, 𝑈(𝑟), for an all-atom force 
field is the total energy of all the covalent interactions including vibrational, bending, and 
torsional energy, as well as non-covalent interactions such as the Lennard-Jones and electrostatic 
potential.43 The potential energy can be calculated using Equation 1.1, where the variables 
highlighted in red are the parameters of the force field. The vibration term requires parameters 
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for the force constant (𝑘bond) and equilibrium bond length (𝑟𝑒) to calculate the vibrational energy 
at a bond length (𝑟). The bending term requires parameters for the force constant (𝑘𝛩) and 
equilibrium angle (𝛩𝑒) to calculate the energy of bending at an angle (𝛩). The torsional potential 
approximates the energy of twisting a bond based on the rotation potential (𝑉𝜙), the multiplicity 
(𝑛), and the phase shift (𝛿) parameters. The non-covalent interaction between particles separated 
by a certain distance (𝑟𝑖𝑗) is modelled through a Lennard-Jones potential which requires 
parameters for the depth of the potential well (𝜀𝑖𝑗) and the distance where the inter-particle 
potential is zero (𝜎𝑖𝑗). Finally, the electrostatic interaction is modelled by a Coulomb potential 
that requires parameters for the charges on the particles (𝑞𝑖  and 𝑞𝑗), where 𝜀𝑜 is simply a constant 
for the permittivity of free space. All of these parameters must be pre-determined by fitting to 
experiment or ab initio calculations. Numerous all-atom force fields exist because there are a 
variety of different methods employed to obtain or estimate these parameters. Due to the many 
design choices inherent in parameterization, force fields yield considerable differences in 
predicted biophysical properties.43   
    After calculating the potential energy of a system using a particular force field, a computer 
simulation employs two mathematical equations in order to propagate the atoms through space 
and achieve a lower energy structure. First, the force on the system (𝑭) is calculated as the 
negative gradient of potential energy (−𝛻𝑈), as seen in Equation 1.2. Then, the Verlet equation 
for the description of motion is used to propagate atoms, as shown in Equation 1.3. In the Verlet 
equation, for a particle with mass, 𝑚𝑖, the future position of a particle (𝑟𝑖(𝑡 + 𝛥𝑡)) is based on 
its current (𝑟𝑖(t)) and previous (𝑟𝑖(𝑡 − 𝛥𝑡)) positions, with a force  (𝐹𝑖(𝑡)) acting on it over a 
time step  𝛥𝑡. 
     A variety of all-atom force fields for proteins have been developed including CHARMM (e.g. 
CHARMM27, CHARMM36), AMBER (e.g. ff03, ff96sb*, ff99sb-ildn-NMR), and OPLS-AA.43 Another 
consideration for all-atom models is that proteins and biological systems are generally studied in 
a water solvent, and so the resolution of the solvent model must also be defined. The solvent 
model employed can be either explicit, such as TIP3P, SPC/E, and TIP4P-EW, or implicit such as 
GBSA.43 Explicit solvent models represent the water molecules and salt ions as explicit particles 
at discrete spatial positions.44 These models are advantageous because protein hydration and 
solvent entropic effects are described according to their fundamental physical interaction, but 
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disadvantageous because they require significant computational time.41 On the other hand, 
implicit water models represent the solvent as a continuous medium with constant dielectric 
permittivity.44 The benefit of implicit solvent is its fast equilibration with the downside that it is 
only an approximation to bulk water and there is no explicit water interacting with the protein. 
Overall, all-atom models most accurately represent the potential energy of system, but they 
require high simulation times and computational resources to simulate large protein 
systems.24,25,42,45,46  
     Coarse grain (CG) force fields enable faster molecular dynamic simulations than all-atom 
models.42,45–50 In CG models, a group of atoms is treated as a virtual particle, or a “bead”, in order 
to decrease the number of particles in a system and reduce the complexity of the force field, 
which leads to significant computational savings.42,45–50 Several protein CG models have been 
introduced, including one-bead,51 two-bead,50 and multiple-beads per residue models,49 as well 
as even much coarser models that have one bead representing multiple residues.52 The most 
popular coarse grain model is MARTINI, which employs an intermediate CG environment where 
four heavy atoms (e.g. not hydrogen) are reduced to one site.49 These coarse-grained models are 
often limited in their use for studying of folding, aggregation, large conformational changes of 
proteins, or conformational features of intrinsically disordered proteins. Due to the loss of 
atomistic information, many coarse-grained simulations of proteins rely on information from its 
native structure in order to apply constraints to maintain its structure. Many of these coarse 
grained models were unsuitable for the study of FOXL1CTERM and FOXL1MUT because the native 
structure of this protein was unknown at the outset of this project.  
     A hybrid model has recently been developed by Wu and coworkers24,25,45,53  which is capable 
of quickly and accurately folding proteins into their native structure without prior structural 
information. This hybrid model, known as PACE,24,25,45,53 was employed to study the structure 
FOXL1CTERM and FOXL1MUT.  
1.3.4.2. PACE Force Field  
     In this research, FOXL1CTERM and FOXL1MUT were represented using the Protein in Atomic details 
coupled with Coarse-grained Environment (PACE).24,25,45 PACE represents protein and ions using 
the united atom (UA) model and represents water using a coarse grain environment developed 
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by Marrink and coworkers.48 In the UA model, each heavy atom and its attached hydrogens are 
usually represented as a single bead,45 as shown in Figure 1.4. However, hydrogen is explicitly 
represented in cases where hydrogen bonding can occur, such as the hydrogen in the backbone 
amide groups and in the side chains of Asn, Gln, Trp, and His. A coarse grain water bead is a sphere 
representing a cluster of four water molecules, as illustrated in Figure 1.5.  
     There were three major motivations for using the PACE force field as opposed to all-atom and 
other coarse grain models. First, simulations using PACE are approximately five to ten times faster 
than conventional all-atom simulations.45 Secondly, PACE was shown to be capable of maintaining 
the native structure of protein in MD simulations, unlike many coarse grain models that require 
artificial constraints.24,25,53 Thirdly, PACE was able to fold proteins from a random coil into their 
native structure. These proteins included a variety of structural motifs including α-helix, β-sheet, 
and mixed structures.45,53 This is especially important in the structural study of FOXL1CTERM and 
FOXL1MUT protein because no experimentally determined or homology model structure was 
available to serve as the starting structure.   
     The total energy of a protein system using the PACE force field is the sum of contributing 
interactions including bonded (𝐸bond), bending (𝐸angle), dihedral (𝐸dihedral), geometry 
(𝐸improper), rotamers (𝐸φ,ψ,𝜒1), water (𝐸CGW−CGW), hydration (𝐸CGW−UA), van der Waals (𝐸vdW), 
polar (𝐸polar), and electrostatic (𝐸ele) interactions, as detailed in Equation 1.4. Han and co-
workers, the developers of the PACE model, parameterized each of these terms. We refer the 
reader to several papers that describe the terms and parameterization in detail.45,47,49,54  
 
𝐸 =  𝐸bond+ 𝐸angle + 𝐸dihedral + 𝐸improper + 𝐸φ,ψ,χ1 + 𝐸CGW−CGW
+ 𝐸CGW−UA + 𝐸vdW + 𝐸polar + 𝐸ele 
(1.4) 
 
     In the PACE force field, the bonding interaction, 𝐸bond, is governed by a harmonic potential 
with a force constant of 𝐾bond  = 1.25 × 10
5 kJ nm−2, as seen in Equation 1.5.  The energy 
associated with bending, 𝐸angle, is imposed with a harmonic potential with  𝐾angle =
300 kJ mol−1 rad2, as shown in Equation 1.6.24 The equilibrium bond lengths (𝑟0) and angles (𝛩0) 
were obtained by fitting these parameters to reproduce the structures obtained from quantum 
mechanical calculations of 15 small molecules.47 
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 𝐸bond = ∑
1
2
b
 𝐾bond,b(𝑟𝑏 − 𝑟0,𝑏)
2 (1.5) 
 
 𝐸angle = ∑
1
2
a
𝐾angle,𝑎(𝛩𝑎 − 𝛩0,𝑎)
2 (1.6) 
 
The dihedral potential, 𝐸dihedral, is made up a sum of cosine functions of the torsional angles and 
the Lennard-Jones potential for the interaction between sites separated by three bonds, as shown 
in Equation 1.7. The torsional potential contains terms for the rotational potential (𝐾dih,𝑑), the 
multiplicity (𝑛𝑑), the dihedral angle (𝜁𝑑), and the phase shift (𝜁0,𝑑). The Lennard-Jones potential 
includes terms for the depth of the potential well (𝜀14,𝑖𝑗) and the distance where the inter-particle 
potential is zero (𝛿14,𝑖𝑗). These parameters were optimized by fitting the quantum mechanical 
torsional potential of 24 minima and 22 rotation barriers of simple molecules.24 𝐸improper is a 
term used to keep planar geometries and chiral centers, which is calculated using Equation 1.8. 
This term is imposed using a harmonic potential on a dihedral (𝜉0) with 𝐾imp  =
 300 kJ mol−1 rad2. The energy of rotamers, 𝐸φ,ψ,𝜒1 , for the backbone (𝜓,  𝜑)  and sidechain  (χ1) 
is composed of a cosine function with different multiplicities (𝑛) and a Lennard-Jones potential 
to model the short-range interaction between a side chain and its adjacent backbone for sites 
separated by more than three covalent bonds.45 The parameters 𝐾dih, 𝜁0𝑛 , 𝜀short,𝑖𝑗, and 𝜎short,𝑖𝑗 , 
which are shown in Equation 1.9, were optimized through iterative equilibrium simulations to 
reproduce Ramachandran plots from a protein data bank coil library through aqueous simulation 
of dipeptides for each of the 20 amino acids.24  
 𝐸dihedral = ∑ 𝐾dih,𝑑[1 + cos(𝑛𝑑𝜁𝑑 − 𝜁0,𝑑)]
𝑑
+ ∑ 4𝜀14,𝑖𝑗 (
𝛿14,𝑖𝑗
12
𝑟𝑖𝑗
12 −
𝛿14,𝑖𝑗
6
𝑟𝑖𝑗
6 )
1−4pair
 (1.7) 
 
 
𝐸improper = ∑
1
2
𝐾imp,𝑖(𝜉0 − 𝜉0,𝑖)
2
𝑖
 (1.8) 
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𝐸φ,ψ,χ1 = ∑ ∑ 𝐾dih𝑛𝑑 ,𝑑
[1 + cos (𝑛𝑑𝜁𝑑 − 𝜁0𝑛𝑑 ,𝑑
)]
𝑁𝑑
𝑛𝑑=1𝑑
+ ∑ 4𝜀short,𝑖𝑗 (
𝜎short,𝑖𝑗
12
𝑟𝑖𝑗
12 −
𝜎short,𝑖𝑗
6
𝑟𝑖𝑗
6 )
short
          
(1.9) 
 
A Lennard-Jones potential, shown in Equation 1.10, is employed to model the interaction 
between CG water (𝐸CGW−CGW), between CG water and protein (𝐸CGW−UA), and between non-
polar protein sites (𝐸vdW). The parameters for the CG water interaction are 𝜀CGW−CGW =
5.0 kJ mol−1 and 𝜀CGW−CGW = 5.0 kJ mol
−1.45 The parameters for the interaction of protein and 
water were optimized by fitting experimental hydration free energies of 35 compounds.45 The 
non-bonded interaction parameters were optimized to fit the density of liquid states and free 
energies of evaporations for eight organic compounds.45 
 𝐸A−B = ∑ 4𝜀𝐴−𝐵,𝑖𝑗 (
𝛿𝐴−𝐵,𝑖𝑗
12
𝑟12
−
𝛿𝐴𝐵,𝑖𝑗
6
𝑟6
)
𝑖≠𝑗
 (1.10) 
 
The interaction between polar groups, 𝐸polar, is calculated using Equation 1.11. The polar 
interaction parameters were optimized by fitting the potential of mean force (PMF) simulations 
to the OPLS-AA/L force field in explicit water. The electrostatic interaction is calculated using 
Equation 1.12, where 𝑞𝑖  and 𝑞𝑗 are atomistic charges, 𝑟𝑖𝑗 is the pair distance, 𝜀0 is the vacuum 
permittivity constant, and 𝜀𝑟  is the relative permittivity constant. The atomic charges were taken 
directly from the OPLS-AA force field.45  
 
𝐸polar = ∑ [4𝜀attr (
𝛿𝑂𝑖−𝑁𝐻𝑗
12
𝑟𝑂𝑖−𝑁𝐻𝑗
12 −
𝛿𝑂𝑖−𝑁𝐻𝑗
6
𝑟𝑂𝑖−𝑁𝐻𝑗
6 ) + 4𝜀rep
𝛿𝑂𝑖−𝐶𝛼𝑗
12
𝑟𝑂𝑖−𝐶𝛼𝑗
12
|𝑖−𝑗|>2
+ 4𝜀rep
𝛿𝑂𝑖−𝐶𝑗−1
12
𝑟𝑂𝑖−𝐶𝑗−1
12 + 4𝜀rep
𝛿𝐶𝑖−𝑁𝐻𝑗
12
𝑟𝐶𝑖−𝑁𝐻𝑗
12 ] 
(1.11) 
 
 
𝐸ele = ∑
𝑞𝑖𝑞𝑗
4𝜋𝜀0𝜀𝑟𝑟𝑖𝑗
𝑖≠𝑗
 (1.12) 
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Figure 1.4: The United Atom representation of the amino acids employed in the PACE model. 
Each bead represents a single interaction site. Adapted with permission from Han et. al.24 
Copyright (2010) American Chemical Society.  
 
Figure 1.5: The coarse grain water used in the PACE model is a van der Waal’s sphere 
representing a cluster of four water molecules, which was developed by Marrink et. al.48  
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1.3.4.3. Replica Exchange Molecular Dynamics 
     Replica exchange molecular dynamics (REMD) is a useful conformation sampling method for 
protein-folding, especially when attempting to fold a protein from a random coil to its native 
state.27,34 In conventional molecular dynamics (MD) simulations, a protein can often become 
trapped in one of many local energy-minimum states. REMD resolves this problem by simulating 
a series of non-interacting replicas at several temperatures ranging from the desired temperature 
to a sufficiently high temperature that enables a replica to overcome energy barriers.27 
Throughout the simulation, the coordinates of temperature-neighbouring replicas can be 
exchanged at periodic intervals, where the probability (𝑃(𝑖 → 𝑗)) of switching coordinates is 
based on Metropolis-Hastings criterion shown in Equation 1.13. In this equation, 𝐸𝑖 / 𝐸𝑗 and 
𝑇𝑖  / 𝑇𝑗  are the potential energy and temperature of the 𝑖
th and 𝑗th replica, respectively, and 𝑘𝑏  is 
the Boltzmann constant. The coordinate exchange of different temperature replicas enables 
greater conformational sampling, and increases the likelihood of determining the native state of 
a protein.27,44 
 𝑃(𝑖 → 𝑗) = min (1 ,   𝑒
(𝐸𝑖−𝐸𝑗)(
1
𝑘𝐵𝑇𝑖
−
1
𝑘𝐵𝑇𝑗
)
) (1.13) 
1.3.4.4. Cluster Analysis 
    Cluster analysis is a technique employed to find the most populated configurations during a 
simulation.55 The process of obtaining clusters from a molecular dynamics trajectory involves first 
calculating the root mean squared deviation (RMSD) of Cα atoms between all pairs of aligned 
structures.56 The RMSD is a measure of the average distance between the atoms of superimposed 
molecules, as seen in Equation 1.14.50 In this equation, 𝑁 is the total number of atoms and 𝛿𝑖 is 
the distance between corresponding 𝐶𝛼  atoms of superimposed structures. The cluster analysis 
process involves calculating for each structure the total number of other structures, or 
“neighbour conformations,” that fall within the specified RMSD cut-off. The structure with the 
highest number of neighbour conformations is taken as the center of the cluster. This center 
configuration is then combined with all of its neighbour conformations to form the first cluster. 
The structures of this cluster are then eliminated from the pool of structures. This process is 
repeated on the smaller pool of structures and continues until the specified number of clusters is 
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met.  The assumption is that the clusters that are more populated are more likely to be the native 
structure.   
 𝑅𝑀𝑆𝐷 =  √∑
1
𝑁
(𝛿𝑖)2
𝑁
1
 (1.14) 
1.4. Methods to Determine Protein Structure  
1.4.1. Introduction 
     Several popular methods that are employed to experimentally investigate protein structure 
include circular dichroism (CD),57–59 electron microscopy,60–62 X-ray crystallography,63,64 and 
nuclear magnetic resonance (NMR).65–67 CD and EM are both low resolution methods, where CD 
can provide overall secondary structure content of proteins and EM can give a low resolution 
image of the overall shape of large proteins. On the other hand, both X-ray crystallography and 
NMR can provide atomic resolution data of the three dimension structure of proteins.  
     The structure of a protein is determined by consolidating experimental data with its known 
amino acid sequence and knowledge of the preferred geometry of atoms in amino acids.  The 
experimental data required includes the diffraction pattern for X-ray crystallography; the 
difference in absorbance between left and right circular polarized light for CD; the distance 
between pairs of atoms that are close in space for NMR; and the image of the overall shape for 
electron microscopy. The method of choice largely depends on the protein studied (size, shape, 
nature, and difficulty of sample preparation) and the desired output information (structure, 
dynamics, shape, or binding). In this thesis, the structure of FOXL1CTERM and FOXL1MUT has thus far 
only been investigated using circular dichroism. However, some theory concerning EM, X-ray 
crystallography, and NMR are discussed below because these are common methods in the field 
of protein structural studies. In order to experimentally investigate the structure of a protein, 
researchers first require a means of producing the protein of interest.68–70 
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1.4.2. Protein Expression 
     Researchers have developed numerous techniques in order to manufacture proteins in the 
laboratory. One method developed to produce short proteins and peptides is chemical synthesis, 
which can make small amounts of very pure peptides.71 However, chemical synthesis is not a 
viable option for large, complex proteins because the reaction is limited by the synthetic 
efficiency of each reaction step, and unfortunately each amino-acid must be added in a stepwise 
fashion.71 For example, a 100 residue peptide with a 97% efficiency for each step provides an 
overall 5% yield.71 Another popular technique is recombinant protein expression, where living 
cells can be harnessed as factories to produce proteins of interest based on a supplied DNA 
template.68 Proteins that are produced from DNA templates are referred to as recombinant 
protein.  
       Recombinant protein expression is accomplished using a host system and DNA template. The 
host can be bacteria, yeast, insect, or mammalian cells, while the DNA source can be a virus, 
plasmid, or artificial chromosome.68 This thesis focuses on employing the most widely used and 
developed expression system which involves using Escherichia coli (E. coli) bacterial host cells with 
a plasmid DNA template.69 The E. coli - plasmid expression system is very popular because 
bacteria are easy to culture, grow rapidly, and can produce high yields of recombinant protein, 
while the plasmid is easy to manipulate genetically.69    
     Figure 1.6 shows the process of recombinant protein expression using an E. coli - plasmid 
expression system. A plasmid is a circular piece of DNA that contains the genetic template 
(construct) that codes for the protein of interest.70 Through heat shock, the cell membrane 
becomes more permeable, allowing the plasmid to be transformed into the E. coli. The cells are 
cultured and induced to overexpress the desired protein.70 During expression, the protein can 
either remain soluble, associate with the cell membrane, or become insoluble as inclusion bodies. 
The cells are then lysed to disrupt its membrane wall, and the protein is released into a medium 
that prevents degradation of the protein. After locating and identifying the protein, usually 
through gel electrophoresis and western blotting, at least two purification steps are generally 
required to separate the protein of interest from other cellular and protein impurities. Once 
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sufficient quantities of relatively pure protein has been acquired, the protein sample can be 
prepared for structural studies. 
 
Figure 1.6: Recombinant protein expression using an E. coli - plasmid expression system. This 
process involves transforming a plasmid into E. coli cells, growing the E. coli cells, and then 
inducing protein expression. Lysing the cells disrupts the membrane and the protein can be 
recovered. The protein can remain soluble, associate with the membrane, or form insoluble 
inclusion bodies. After purification, structural investigation of the protein can begin.   
 
     One problem often faced during recombinant protein expression is that there is little or no 
expression of the foreign gene.69 In order to increase the quantity of protein expressed, numerous 
variables can be changed or manipulated such as  the strain of the E. coli and the DNA template.68 
First of all, there are many different types of genetically altered E. coli strains that were developed 
to express foreign genes. One E. coli strain may be more suited than another to express a 
particular foreign gene.69 Table 1.1 list a few strains of E. coli and the purpose for which they were 
developed. These were the strains investigated to express FOXL1CTERM/MUT. A second variable that 
can be manipulated is the DNA template. If a protein gene is difficult to express individually, then 
the DNA template can be modified to contain the protein gene fused to one or more other 
protein/peptide genes that stabilize the expression.68,69 These so-called “tags” can increase yields, 
facilitate protein detection/identification, increase solubility, and assist with purification of the 
protein.68,69  Table 1.2 lists a few tags and their purpose. These tags were employed to assist with 
the expression, identification, and purification of FOXL1CTERM and FOXL1MUT.  
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Table 1.1: Several strains of E. coli used in recombinant protein expression.69 
E. coli Strain Purpose 
C41(DE3) Overexpressing toxic protein 
C43(DE3) Express a gene which codes for membrane and globular protein 
BL21(DE3) pLys S 
Unable to degrade foreign recombinant protein because of two deleted 
protease genes (Lon and OmpT) 
Controlled expression to prevent leaky expression of toxic gene 
 
Table 1.2: Some common tags used in recombinant protein expression.68,69 
Tag Purpose 
6His-tag Affinity tag composed of six consecutive histidine residues used for 
purifying recombinant proteins and detection via western blot 
S-tag Affinity tag composed of a 15-residue peptide used for purification and 
colorimetric detection via western blot 
SN-fusion Staphylococcus aureus nuclease (SN) fusion protein employed to stabilize 
expression of the gene 
 
     One of the most important techniques for isolating and purifying proteins is chromatography.70 
Two commonly employed chromatography techniques are size exclusion gel filtration and affinity 
chromatography.70 In size exclusion gel filtration, a mixture of molecules are separated on the 
basis of size. In this technique, a sample is passed through a column of porous beads. Since larger 
analytes cannot enter as many porous beads, they experience a smaller volume path to travel 
and are eluted first. In affinity chromatography, an analyte that has an affinity for a column binds 
to it while the other impurities are eluted from the column. The protein of interest is then eluted 
from the column by addition of a reagent that competes for the binding sites. For example, a Ni 
affinity columns can bind a 6His-tag containing protein for purification.69,70 The negatively charged 
His residues interact with Ni2+ that has been immobilized on a matrix. The 6His-tagged protein 
remains on the column, while low concentrations of imidazole is employed to wash the column 
to remove impurities. The protein can be recovered by eluting the column with an imidazole 
solution with an increasing concentration gradient.  
     Two techniques that are employed to identify and characterize the composition of a protein 
mixture are gel electrophoresis72 and western blotting73 as shown in Figure 1.7. Gel 
electrophoresis is a technique that yields information about the size, purity, and relative amount 
of proteins in a sample.70 To perform gel electrophoresis, samples are loaded into lanes on a gel, 
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where one of the lanes is reserved for a reference ladder. Under the influence of an electric 
current, the proteins migrate down the gel, with lower molecular weight proteins migrating faster 
than larger proteins. Upon staining the gel (i.e. Coomassie or silver staining), the protein bands 
become visible. The size of the protein can be assessed by comparing a band to the reference 
ladder, which has colored bands of known molecular weight. If a lane has more than a single band, 
then that sample is impure. Also, larger bands on a gel have more protein than smaller bands, 
which gives an indication of the relative amounts of protein in a sample. However, if the 
concentration of a protein sample is too low, it may not be visible on the gel.      
     Although electrophoresis is an effective technique to determine the size, purity, and relative 
amount of protein in a sample, it provides no experimental data to prove the identity of any of 
the protein bands besides their approximate molecular weight. On the other hand, western 
blotting is a technique that enables a protein to be positively identified. In this method, gel 
electrophoresis is run and the sample is then transferred from the gel to a synthetic membrane.73 
The transferred blots can then be probed with antibodies that bind only to specific proteins in 
order to confirm the identity of the protein of interest. To enable easy identification via western 
blot, recombinant proteins are often designed to have a peptide tag, such as the His-tag, that 
binds to commercially available antibodies.73      
     Once sufficient quantities of relatively pure protein has been acquired, the protein sample can 
be prepared for structural investigation by circular dichroism, electron diffraction, X-ray 
crystallography or nuclear magnetic resonance. 
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Figure 1.7: Two techniques used to characterize protein samples are (left) gel electrophoresis 
and (right) western blot. Gel electrophoresis allows the size, purity, and relative quantities of 
proteins in each sample to be determined. For example, lane 1 (L.1) shows a colored referenced 
ladder where the bands have molecular weight of 10 kDa (red), 20 kDa (blue), and 30 kDa (grey); 
lane 2 (L.2) is an impure sample because it has two bands of similar amounts at approximately 
15 kDa and 20 kDa; lane 3 (L.3) is a potentially pure sample with a protein of 30 kDa; lane 4 (L.4) 
reveals that if a protein sample is not concentrated enough, it will not show up on a gel upon 
staining. A western blot probes for the protein of interest using antibodies, and only proteins 
that interact with the antibodies appear.  
1.4.3. Circular Dichroism  
     Circular dichroism (CD) is a spectroscopic technique that can be employed to analyze the 
secondary structure content of a protein.57–59 This technique is also used to determine how 
factors like mutations, temperature, pH, ionic strength, ligands, denaturants, and binding 
interactions affect the conformation and stability of a protein.57,58 CD is particularly advantageous 
in protein studies because it is a rapid, non-destructive technique that only requires a small 
amount of proteins (~ 20 µg) in physiological buffers for secondary structural characterization. 
     The circular dichroism phenomenon in proteins originates from the carbon atom that is 
adjacent to the peptide bond, referred to as Cα.57,59 The Cα atom is bonded to four different 
constituents in all amino acids (except glycine), making it a chiral center and asymmetric.59 The 
chirality of the Cα atom creates asymmetry in the peptide bond chromophore.59 When left and 
right circular polarized light passes through a protein sample, the amide bond undergoes an 
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electronic transition, either 𝑛 → 𝜋∗ or 𝜋𝑜 → 𝜋
∗, that absorbs light between 215 – 230 nm or 185 
– 200 nm, respectively.57 These individual peptide bond chromophores can couple differently with 
each other based on the secondary structure conformation of the protein, inducing an overall 
chirality which causes different amounts of left of right circularly polarized light to be absorbed.59 
CD measures the difference between the absorption of left and right circularly polarized light over 
a range of wavelengths to yield a spectrum, the shape of which is sensitive to the secondary 
structure of a protein. 
     Figure 1.8 shows a representative shape of a CD curve based on the secondary structure of a 
protein. Proteins that are primarily 𝛼-helical show characteristic negative bands at 222 nm and 
208 nm, and a positive band at 193 nm. Anti-parallel β-sheet proteins have a negative band at 
218 nm and a positive band at 195 nm. Randomly coiled proteins (such as denatured or 
intrinsically disordered proteins) have a negative band at 195 nm and show low ellipticity at 
wavelengths greater than 210 nm. In the case of a protein with multiple secondary structure 
motifs, we assume to a first approximation that the resultant spectra is a linear combination of 
the individual structures.57,58     
     Several sample requirements for CD concern its purity, solvent, and concentration. To obtain 
a reliable CD spectrum, the sample should be 95% pure as measured by gel electrophoresis.58 
Secondly, it is imperative to avoid solvents that strongly absorb light in the acquisition range (190 
nm – 260 nm).58 Thirdly, solids suspended in the solvent can scatter the light and therefore must 
be removed. Finally, the concentration of the protein should be known accurately in order to both 
acquire a representative CD spectra and estimate the secondary structure.      
     Although CD provides secondary structure information, it does not yield residue-specific 
details required for tertiary structure characterization. Tertiary structure information can be 
obtained from techniques like electron microscopy, X-ray crystallography, or nuclear magnetic 
resonance.  
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Figure 1.8: Representative circular dichroism spectra showing the differential absorption 
between left and right circularly polarized light as a function of wavelength for several protein 
samples. The shape of the curve reveals the secondary structure content of proteins: 𝜶-helix 
has negative minima at 222 and 208 nm, and a positive maximum at 193 nm; 𝜷-sheet has a 
negative minimum at 218 nm and a positive maximum at 195 nm; random coil has a negative 
minimum at 195 nm and low absorbance greater than 210 nm.  
 
1.4.4. Electron Microscopy 
     Electron microscopy (EM) is a technique that can be employed to determine the structure of 
large macromolecular complexes.60–62 In an EM experiment, a beam of electrons interacts with a 
specimen to yield 2D images of the biomolecule in a range of orientations.60 These 2D images can 
be aligned, averaged, and combined computationally to create a 3D reconstruction of the 
macromolecule.61,62    
     EM is particularly well suited for structural studies of macromolecules that are difficult to 
crystalize such as proteins with intrinsically disordered regions.60 Disordered or flexible regions 
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are revealed by a reconstructed image that appears fuzzy and unresolved even with increasing 
number of averaged images. One major advantage of EM over X-ray and NMR is that the output 
is images as opposed to complex data that must be interpreted. Unfortunately, EM is a 
destructive method since the electron beam causes radiation damage to biological samples.60–62 
Another downside is that biological samples display low contrast images because the sample is 
composed of mostly light elements.60  Also, although tertiary structure information can be 
extracted from electron microscopy, these experiments rarely produce atomic level detail. EM 
studies are often combined with experiments that can obtain atomic level detail like X-ray 
crystallography or nuclear magnetic resonance. One final limitation is that biomolecules must be 
larger than 100 kDa.60 Thus, EM is not a viable technique for structural studies for FOXL1 which 
only has a molecular weight of 36.49 kDa.  
1.4.5. X-ray Crystallography 
     X-ray crystallography is an experimental method that can provide atomic resolution detail of 
the structure of a protein.63,64 In this technique, an intense beam of X-rays strike a crystal and are 
scattered by the electrons of atoms to produce an overall diffraction pattern. The diffraction 
pattern contains information about the distribution of electrons, which is interpreted to 
determine the arrangement of atoms in the crystal.74  
     Most of the structures that are listed in the Protein Data Bank (PDB) were determined using X-
ray crystallography because it can provide the structures of proteins of any molecular size with a 
resolution of ~1 - 3Å.64 This technique requires a crystal that is large (> 0.1 mm diameter) and 
regular in structure, which does not have significant imperfections like cracks.63,64,74 X-ray 
crystallography is an excellent choice for rigid proteins that form ordered crystals, but 
unfortunately does not work well for flexible, disordered proteins that do not necessarily pack 
into an ordered, crystalline structure. In fact, disordered regions of crystallized proteins are often 
hard to observe in the electron density maps determined from X-ray crystallography.63 
1.4.6. Nuclear Magnetic Resonance 
    In order to obtain accurate information about protein function, it is important to study their 
structure as close to the natural state as possible. Nuclear magnetic resonance (NMR) has been 
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employed to solve the three-dimensional structure of many proteins in their natural solution 
state.67,75–78 The studies of proteins by NMR are based on acquiring information concerning 
through-bond and through-space connectives.79 NMR techniques based on scalar coupling, the 
coupling between two nuclei that are connected via bonds, can be used to identify connectivity 
between nuclei, facilitate resonance assignment, and give information on torsion angles to yield 
more accurate structures.80 NMR techniques based on dipolar coupling, the coupling between 
two nuclei that are close in space, can be used to attain three-dimensional structural information 
for proteins.81 
     For small proteins and peptides, through-bond and through-space interactions are most 
conveniently obtained by two-dimensional (2D) NMR methods. Common homonuclear 1H 2D 
techniques used to acquire scalar coupling information include COSY and TOCSY,82 and to obtain 
dipolar coupling correlations are 2D NOESY or 2D ROESY. 2D 1H NMR studies are generally limited 
to proteins less than 10 kDa.80 In larger proteins, an overwhelming number of interactions lead 
to overlap and degeneracy issues in the resulting spectrum, which prevents the unambiguous 
assignment of the peaks.77 Consequently, three-dimensional NMR is becoming the method of 
choice for structural studies of proteins by NMR because of its ability to reduce the extent of 
spectral overlap by extending 2D peaks into a third dimension. However, for the structural study 
of FOXL1CTERM and FOXL1MUT, both of which have a molecular weight less than 10 kDa, the first 
NMR methods that should be employed to obtain through-bond and through-space connectivity 
information are 2D TOCSY82 and 2D NOESY,81 respectively. 
1.4.6.1. TOCSY 
     Two-dimensional total correlation spectroscopy (2D TOCSY) is a homonuclear 1H NMR 
technique that uses consecutive scalar couplings to correlate all hydrogens within a spin system, 
as seen in Figure 1.9. The technique is also known by the acronym HOHAHA for homonuclear-
Hartmann-Hahn.82 
     TOCSY is especially applicable to molecules that are intrinsically composed of separated groups 
of coupled spins.80 Two nuclei are coupled if they are within three bonds of each other. A spin 
system is a collection of nuclei (e.g. protons) that are directly or indirectly coupled to each other 
by consecutive spin coupling. In the case of proteins, each amino acid constitutes one or more 
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independent spin systems, owing to the carbonyl carbon which breaks any scalar coupling 
between adjacent amino acids as shown in Figure 1.10. Thus, TOCSY is very applicable to proteins, 
because each amino acid gives characteristic TOCSY signal patterns, which assists in the 
identification of resonances on an NMR spectrum.83 
     TOCSY has a few limitations. First of all, TOCSY only shows local connectives within a spin 
system. As a result, a particular amino acid can be identified on a TOCSY spectrum, but the 
location of that residue in relation to its amino acid sequence cannot usually be elucidated 
exclusively from a TOCSY analysis, especially if there are several of the same amino acid in the 
sequence. Thus, it is usually necessary to supplement TOCSY data with spatial connectivity 
information.   
 
 
 
 
 
 
Figure 1.10: Each amino acid in a protein is its own independent spin system. The spin systems 
for a five residue peptide are highlighted. Some amino acids such as phenylalanine and 
asparagine contain two spin systems while others like lysine, aspartate, and glycine have a 
single spin system.   
Figure 1.9: Scalar coupling between a network of coupled spins. A TOCSY cross peak is observed 
between each pair of hydrogens within a spin system.  Since the hydrogen in grey is not part of the 
larger spin system, no cross peaks between it and the other hydrogen are observed.   
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1.4.6.2. NOESY 
     Two-dimensional nuclear Overhauser effect spectroscopy (2D NOESY) is a homonuclear 1H 
NMR experiment that correlates protons that are close in space.81 It is a widely used technique in 
structural studies of proteins because short internuclear distances can be used to determine how 
the amino acids are oriented with respect to each other in space.  
     A 2D NOESY spectrum contains diagonal peaks and symmetrically placed cross peaks.81 The 
diagonal peaks result from magnetization that remained on the first spin during the mixing 
sequence, and thus give no structural information. On the other hand, a cross-peak connecting 
two signals implies the protons are close in space, usually less than 5 Å.65 However, in severe spin 
diffusion cases, where magnetization is exchanged spontaneously between spins, cross-peaks for 
protons that are greater than 5 Å apart can appear on a NOESY spectrum.80 As a result, for 
proteins, the mixing time is kept to a minimum between 100-200 ms to prevent spin diffusion.80 
Other undesirable peaks that may arise are chemical exchange peaks because, like NOEs, they 
involve a transfer of magnetization between nuclei. As a general note, unlike scalar coupling, 
dipolar coupling in the solution state does not cause splitting of the signals.79  
     The knowledge of through-space interactions from NOESY data can assist in both the 
assignment of resonances and the structural determination of proteins.2,84 NOESY is extremely 
useful for connecting adjacent amino acids because hydrogen in adjacent spin systems will almost 
always be close in space.79 This will help assign the resonance peaks of each residue (obtained 
from 2D TOCSY) relative to its position in the amino acid sequence. Furthermore, since secondary 
structural elements show characteristic through-space interactions, a NOESY spectrum can be 
analysed for the presence or absence of these peaks to determine whether sections of the protein 
possess these secondary structure elements.84 In addition, NOEs occurring between hydrogens 
far apart in the amino acid sequence yield information on how the protein is folded in 3D. Finally, 
the intensity of a NOESY cross peak is proportional to 1 𝑟𝐴𝐵
6⁄ , where 𝑟𝐴𝐵 is the inter-proton 
distance.66 Thus, more intense cross peaks generally denote protons that are closer in space.    
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1.5. Goals 
     The long term goal of this research is to determine how the deletion of GIPFL in the mutant 
FOXL1 protein leads to a human genetic disease. Before this objective can be achieved, a 
structural study of FOXL1CTERM and FOXL1MUT must first be performed. This thesis sets out to 
determine the structure of FOXL1CTERM and FOXL1MUT using bioinformatics, computational 
simulations, and experimental methods. In this thesis, several bioinformatics tools were first 
employed to predict protein disorder, secondary structure, and sequence alignment of these 
proteins. As will be shown, the bioinformatics tools predicted that the GIPFL mutation occurs in 
an ordered, structured, evolutionarily-conserved portion of the C-terminal domain of FOXL1. In 
addition, computational simulations were also performed that combined the PACE model and 
replica exchange molecular dynamics to determine the most statistically probable structures of 
both FOXL1CTERM and FOXL1MUT. These computational results predict that the deletion of GIPFL in 
FOXL1MUT protein disrupts its hydrophobic core and causes it to become more disordered than 
FOXL1CTERM. Finally, experimental progress was made towards expressing and purifying both 
FOXL1CTERM and FOXL1MUT through recombinant protein expression. Preliminary structural data 
was obtained using circular dichroism which indicated that FOXL1CTERM has a predominantly 
helical secondary structure while FOXL1MUT was partially helical with some randomly coiled 
regions. The combination of bioinformatics, computer simulations, and preliminary experimental 
results strongly suggests that the GIPFL deletion increases the disorder of the FOXL1MUT protein 
in comparison to FOXL1CTERM.  
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Chapter 2  
Methodology 
2.1. Computational  
    The computer simulations were performed with the VMD software package (version 1.9.1).85 
The structure of the most C-terminal 69 residues of wildtype FOXL1 (FOXL1CTERM) and 
corresponding residues of the deletion mutant (FOXL1MUT) were deduced by molecular dynamics 
simulations. The initial structures of these proteins were generated in an extended state and were 
coarse-grained (CG) based on the united-atom (UA) model and then solvated in coarse grain 
water (CGW) molecules with an additional 10 Å of water padding. All non-bonded interactions 
were shifted to zero between distances of 9 Å and 12 Å. The time-step for all simulations was set 
to 5 fs. Pair lists were updated at least once per 10 steps, with a 12 Å pair list cut-off. A Langevin 
thermostat with a damping coefficient of 10 ps-1 was employed to maintain temperature. The 
solvated system was energy minimized with the PACE coarse grain force field.24,25 The minimized 
system was then equilibrated for 3.5 ns and then submitted for a 20 ns simulation using the 
canonical NPT ensemble at 300 K and 1 bar pressure. The constant pressure of 1 atm was 
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maintained with a Nosé-Hoover Langevin piston barostat86,87 using a piston period of 100 fs and 
a decay time of 50 fs. The waters were then removed, and the protein was re-solvated in a cubic 
box with a side length of 90 Å and neutralized by the addition of a single sodium cation. This 
system was then minimized, equilibrated (3.5 ns), and submitted for a 5 ns simulation, all using a 
canonical ensemble at 300 K.  In this equilibration, the backbone atoms (Cα, the amide N, and the 
carbonyl carbon) of the protein were fixed. 
     Replica exchange molecular dynamics was then employed to fold the protein and sample 
various configurations. The REMD simulations contained 32 replicas with temperatures ranging 
from 300 K to 500 K.†† Each replica started with the same conformation resulting from the 
molecular dynamics equilibration. Exchanges were attempted every 0.05 ns, having an 
acceptance rate of about 15%. A 4000 ns replica exchange simulation was performed, where the 
configurations are saved at every 0.05 ns. The full simulation at 300 K was used for analysis. The 
dominant structure in the 300 K replica was determined by clustering analysis based on the root 
mean squared distance (RMSD) of all Cα atoms. Clustering analysis was performed in the VMD 
1.9.1 program using a 3 Å RMSD criteria.55  
2.2. Experimental 
2.2.1. General  
     Three different constructs (1) 6His—FOXL1CTERM/MUT, (2) S-tag—6HIS—FOXL1CTERM, and (3) SN—
FOXL1CTERM/MUT—6HIS were investigated in order to determine the structure of FOXL1CTERM and 
FOXL1MUT. The first construct investigated, 6His-FOXL1CTERM/MUT, had low protein expression and 
significant sample impurity. The second construct studied, S-tag—6HIS—FOXL1CTERM, also had low 
protein expression and sample impurities, but allowed for identification of the target protein by 
western blot and enabled structural characterization of an impure target protein by circular 
dichroism. The final construct, SN— FOXL1CTERM/MUT—6HIS, had high expression yields, was easily 
                                                             
††The temperatures for each of the 32 replicas in kelvin are: 300, 304.98, 310.05, 315.20, 320.44,  325.76, 
331.18, 336.68, 342.27, 347.96, 353.74, 359.62, 365.59, 371.67, 377.84, 384.12, 390.50, 396.99, 403.59, 
410.29, 417.11, 424.04, 431.08, 438.25, 445.53, 452.93, 460.46, 468.11, 475.88, 483.79, 491.83, 500 
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identified via western blot, was successfully enriched, and allowed for some structural 
characterization of the target protein by circular dichroism.  
The expression and characterization for the most promising construct (3) SN—
FOXL1CTERM/MUT—6His is discussed in detail first. Then, the similar (but concise) expression details 
for construct (1) 6His—FOXL1CTERM/MUT and (2) S-tag—6HIS—FOXL1 CTERM, are then discussed.  
2.2.2. Construct 3: SN—FOXL1 CTERM/MUT—6His  
2.2.2.1. Transformation 
     A gene that coded for the SN—FOXL1CTERM—6His (or SN—FOXL1MUT—6His) protein construct 
was synthesized and inserted into the pet29a(+) vector by GenScript (New Jersey, USA). C43(DE) 
Escherichia coli (E. coli) overexpress competent cells were removed from the −80 °C freezer and 
thawed for 20 minutes on wet ice. 1 µL of vector was added to 50 µL of cells on ice and stirred 
gently with a pipette tip. This sample was incubated on ice for 30 minutes. The cells were then 
heat shocked in a 42 °C water bath for 45 seconds, and placed back on ice for 2 minutes for 
recovery. 950 µL of room temperature expression recovery medium - composed of 2xYT (16 g/L 
tryptone, 10 g/L yeast, and 5 g/L NaCl) - was added to the cells in the culture tube. Tubes were 
placed in a shaking incubator at 175 rpm for 1 hour at 37 °C. 50 µL and 100 µL samples of 
transformed cells were spread onto separate agarose plates, which were composed of 2xYT and 
30 µg/mL of kanamycin antibiotic. The plasmid gave kanamycin resistance to the cells that 
underwent transformation, while cells that did not take up the plasmid died. The plates were 
incubated overnight at 37 °C. One isolated colony was obtained from the agar plate using a sterile 
toothpick and placed in 5 mL of 2xYT with 30 µg/mL of kanamycin, and then incubated for 5 hours 
at 37 °C and 175 rpm.  
2.2.2.2. Stock Sample Preparation 
     Stock samples of successfully transformed bacteria were made by combining 500 µL of bacteria 
cells with 500 µL of glycerol into Eppendorf tubes. These samples were stored at −80 °C. 
Subsequent protein expression started from these stocks.  
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2.2.2.3. Protein Expression   
     An overnight culture was prepared containing 500 µL of the transformed sample (or one of the 
stock samples from Section 2.2.2.2), 30 µg/mL of kanamycin, and 75 mL of sterile 2xYT, and then 
incubated overnight at 175 rpm and 37 °C. 10 mL of overnight culture was added to each of 6×4 
L conical flasks containing 1 L of sterile 2xYT with 30 µg/mL of kanamycin. The sample was 
incubated at 175 rpm and 37 °C until a UV absorbance of approximately 0.6 at 600nm was reached 
(~2.5 hours). Then, 500 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to each 
1 L flask to induce cells to make protein. The sample was incubated for 3 hours at 175 rpm and 
37 °C. Mixture was spun in centrifuge at 5000 rpm for 30 minutes. The media was discarded and 
the pellet was collected. 25mL of 5 mM phenylmethylsulfonyl fluoride (PMSF - a serine protease 
inhibitor) in tris-buffered saline (TBS) was added to the pellet.  
2.2.2.4. Cell Lysis 
     A French press or sonication was employed to disrupt the bacterial cell membrane and recover 
the protein. For cell lysis via French press, the bacteria cells were ran through a French press three 
times using a pressure of 12000 psi to disrupt the cells. The cells were collected in a chilled 
Erlenmeyer flask.   In order to disrupt cells via sonication, the sample was sonicated fifteen times 
for 20 seconds, with one minute breaks between each cycle. Cells were kept on ice for the entire 
duration.  
2.2.2.5. Locate Protein 
     A successfully expressed protein can be (a) in the supernatant (b) associated with the 
membrane, or (c) in inclusion bodies. In order to determine the protein’s localization, the lysate 
was separated into these three fractions and the protein visualized. In this case, the expressed 
protein was found in inclusion bodies.  
(a) Supernatant: The cell lysate mixture was centrifuged for 30 minutes at 4 °C and the 
soluble layer was decanted off the pellet. The remaining pellet was kept for the 
“associated with membrane” sample below. To the supernatant, 5 g of DE52 
(diethylaminoethyl, anion exchange pre-swollen whatman cellulose resin) that was 
equilibrated in TBS was added and spun for 1 hour at 4 °C. Sample was centrifuged 
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for 20 minutes at 4 °C and 10000 rpm. The supernatant was decanted off the DE52 
and the resin was discarded. This solution is the “crude soluble” layer discussed later 
in the results section.  
 
(b) Associated with the membrane: To the pellet from (a), 25 mL of 0.2% (w/v) 3-(3-
(cholampidopropyl) dimethylammonio)-1-propanesulfonate (CHAPS) detergent in 
TBS was added and spun in the cold room for 1 hour.  Sample was centrifuged for 20 
minutes at 4 °C and 10000 rpm. Detergent soluble layer was decanted off. The 
remaining pellet was kept for the “inclusion bodies” below. To the solution, 5 g of 
DE52 equilibrated in detergent solution was added and spun for 1 hour at 4 °C. The 
detergent soluble layer was decanted off DE52 and the resin was discarded. At this 
point, this solution is the “crude, associated with the membrane” sample discussed 
later in the results section.   
 
(c) Inclusion bodies: To the pellet from (b), 25 mL of 6 M urea, 0.2% CHAPS, in TBS was 
added and spun in the cold room for 1 hour. Sample was centrifuged for 20 minutes 
at 4 °C and 10000 rpm. To this solution, 5 g of DE52 equilibrated in 6 M urea, 0.2% 
CHAPS, in TBS solution was added and then spun for 1 hour at room temperature. 
The soluble layer of the centrifuged material was decanted off DE52 and the resin 
was discarded. At this point, this solution is the “crude inclusion body” sample 
discussed later in the results section. 
2.2.2.6. Ni Affinity Column Purification  
     To initially purify the crude samples, nickel-bound immobilized metal ion affinity 
chromatography (IMAC) was employed. This is done in order to separate the expressed protein 
(SN—FOXL1CTERM—6His) from other cellular and protein impurities.  
     First, a Ni column was prepared and equilibrated with one of the buffers listed in Table 2.1.  
Imidazole (imdzl) was added to the crude sample from Section 2.2.2.5 to match the imidazole 
concentration in the equilibration buffer. The sample was then run through the prepared Ni 
column and the flow-through was collected. The target protein binds to the Ni column via the 
attached 6His-tag, while many other impurities elute in the flow-through and wash. 25 mL of 
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starting buffer was used to wash the column, which was collected as 3×8.3 mL washes. The target 
protein was then eluted from the Ni column with increasing concentrations of imidazole using 
one of the elution schemes (detailed in Table 2.1) and collected as ~1 mL fractions.  
 
Table 2.1: Several elution schemes used for Ni affinity column purification 
No. Ni column details  
1 Initial column equilibration: 5 mM imidazole in 6 M urea and TBS  
Elution: 10 mL of each of 5, 10, 20, 50, 100, 200, and 300 mM imidazole in 6 M urea 
and TBS 
2 Initial column equilibration: 5 mM imidazole in 6 M urea, 0.2% CHAPS, TBS  
Elution: 10 mL of each of 5, 10, 20, 50, 100, 200, and 300 mM imidazole in 6 M urea, 2% 
CHAPS, TBS 
3 Initial column equilibration: 5 mM imidazole in TBS  
Elution: 10 mL of each of 5, 10, 20, 50, 100, 200, and 300 mM imidazole in TBS 
4 Initial column equilibration: 15 mM imidazole in 6 M urea, 0.2% CHAPS, TBS 
Elution: 10 mL of each of 15, 25, 50, 75, 100, 200, and 300 mM imidazole in 0.2% 
CHAPS, 6 M urea, TBS 
5 Initial column equilibration: 20 mM imidazole in 6 M urea, 0.2% CHAPS, TBS 
Elution: 10 mL of each of 20, 50, 100, 200, and 300 mM imidazole in  6 M urea, 0.2% 
CHAPS, TBS 
6 Initial column equilibration: 20 mM imidazole in 6 M urea, 0.2% CHAPS, TBS 
Elution: 10 mL × 20 mM; 20 mL × 50 mM; 20 mL × 100 mM, 10 mL × 200 mM, 10 mL × 
300 mM imidazole in 6 M urea, 0.2% CHAPS, and TBS 
7 Initial column equilibration: 20 mM imidazole in 6 M urea and TBS 
Elution: 10 mL of 5, 10, 20, 50, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 280, 290, 
200, 300 mM of imidazole in 6 M urea and TBS 
8 Initial column equilibration: 5 mM imidazole in 0.2% CHAPS and TBS 
Elution: 10 mL of 5, 10, 20, 50, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 280, 290, 
200, 300 mM of imidazole in 0.2% CHAPS and TBS 
 
2.2.2.7. UV Detection 
     The UV-vis absorbance of the eluted fractions was measured at 280 nm using the relevant 
solvent as a blank. The 280 nm wavelength probes for aromatic amino acids in proteins including 
tryptophan, tyrosine, and phenylalanine.70 Peaks in a plot of “absorbance vs. fraction number” 
generally indicates the presence of protein. 
     The concentration (in mg/mL) of a protein can be approximated using Equation 2.1, where 
𝐴280 is the UV absorbance at 280 nm, MM is the molar mass of the protein, 𝑙 is the path length 
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of the cuvette (usually 1 cm), and 𝜀280 is the molar absorptivity (𝑀
−1𝑐𝑚−1) of the protein at 280 
nm. The molar absorptivity (𝜀280) can be approximated from the number of tryptophan (𝑛𝑇𝑟𝑝), 
tyrosine (𝑛𝑇𝑦𝑟), and disulfide bonds (𝑛𝑠−𝑠) in a protein using Equation 2.2.
70  
 𝐶 =  
𝐴280 × 𝑀𝑀
𝜀280  × 𝑙
 (2.1) 
 
 𝜀280 = 5550 × 𝑛𝑇𝑟𝑝 + 1490 × 𝑛𝑇𝑦𝑟 + 125 ×  𝑛𝑠−𝑠 (2.2) 
2.2.2.8. Gel Electrophoresis 
     Tris-tricine polyacrylamide gel electrophoresis (PAGE) was employed to determine if the 
protein was successfully expressed and to locate the protein. The most promising fractions were 
first determined by UV-vis. 50 µL of each fraction was combined with 25 µL of tricine-sample 
buffer in an Eppendorf tube and heated for 5 minutes in boiling water. 40 µL of each sample was 
loaded into the lanes of a 16.5% tris-tricine gel (unless otherwise specified). The gel was run at 90 
V until the tricine dye was ~1 cm from the end of the gel. The gel was then Coomassie or silver 
stained.  
a) Coomassie stained: The gel was stained using Coomassie-blue for one hour and then de-
stained until protein bands appeared using a 200 mL solution composed of 20 mL of 
ethanol, 14 mL of glacial acetic acid, and 166 mL of distilled water.  
 
b) Silver stained: The gel was placed for 20 minutes in fixing solution, which is composed of 
50 mL of methanol, 10 mL of glacial acetic acid, 10 mL of fixative enhancer concentrate 
and 30 mL of distilled water. Then the gel was washed 2×10 minutes with distilled water. 
The gel was then silver stained until bands appeared using a solution of 17.5 mL of 
distilled water, 2.5 mL of silver complex solution, 2.5 mL of reduction moderator solution, 
2.5 mL of image development reagent, and 25 mL of room temperature development 
accelerator solution. After staining, 25 mL of 5% glacial acetic acid was used for 15 
minutes to stop the reaction. 
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2.2.2.9. Western Blot 
     Gel electrophoresis (without staining) of a sample was first run using an electrophorator. A 
polyvinylidene fluoride (PVDF) membrane was activated by placing it in methanol for 5 seconds, 
then rinsed twice with distilled water. The gel and PVDF membrane were both equilibrated for 30 
minutes in 10 mM of 100 mL of 3-(cyclohexylamino)-1 propane sulfonic acid (CAPS) transfer buffer 
that had 10% (v/v) methanol. Then, six chromatography sheets (8 cm × 6 cm) were cut and 
equilibrated in the transfer buffer. The stacking rack was prepared with the gel and membrane in 
the center, three chromatography papers on both sides, and sponges (soaked with transfer 
buffer) on the outside. The stacking rack was then placed in the western blot transfer apparatus 
and filled with transfer buffer. The western blot transfer apparatus was then employed to transfer 
protein from the gel to the membrane at a low voltage of 50 V for 2 hours. PDVF membrane was 
placed in blocking reagent (3% skim milk powder in Tween tris buffered saline (TTBS), where TTBS 
is composed of 50 mM Tris HCl, 150 mM NaCl, and 0.1% Tween 20, at pH 7.4) for over one hour. 
The blocking reagent was replaced with primary antibody and incubated overnight on a shaker. 
The membrane was washed with 3×25 mL of TTBS for 5 minutes each with gentle agitation. 
Secondary antibody was added and then placed on a shaker for 2 hours. The membrane was 
washed with 3×25 mL of TTBS for 5 minutes each with shaking. Then a color reaction or chemi-
luminescence reaction was employed to detect protein blots. The type of primary, secondary, and 
detection reaction used depends on the type of western blot ran. The different types of western 
blots discussed in this manuscript are detailed below.  
a) His-tag western: The primary antibody was a 1:3000 (v/v) dilution of monoclonal anti-
polyhistidine antibody found in mouse (Sigma, St. Louis, MO) in 1.25% milk powder in 
TTBS. The secondary antibody was a 1:5000 (v/v) dilution of anti-mouse IgG (whole 
molecule) in alkaline phosphatase conjugate developed in goat (Sigma, St. Louis, MO) in 
30 mL of TTBS. To perform the color reaction, the membrane was equilibrated for 10 
minutes with 20 mL of 0.1 M NaHCO3, 1 mM MgCl2 at pH=9.8. The substrate was prepared 
in the dark, and contained 60 µL of BCIP (5-bromo-4-chloro-3-indolyl phosphate), 120 µL 
of NBT (nitro blue tetrazolium chloride) in 0.1 M NaHCO3, 1 mM MgCl2 at pH=9.8. 
Substrate was added to membrane and covered in tinfoil until bands appeared. TE buffer 
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at pH 8 (10 mM Tris, 1 mM ethylenediaminetetraacetic acid (EDTA)) was added to 
membrane to stop the reaction. 
 
b) SN western: The primary antibody was a 1:1000 (v/v) dilution of Staphylococcus aureus 
nuclease (SN) antibody produced in rabbit (MyBioSource, San Diego, CA) in 1.25% milk 
powder in TTBS. The secondary antibody was a 1:2000 dilution of anti-rabbit IgG 
produced in goat (Sigma-Aldrich, St. Louis, MO) in 20 mL of TTBS. To perform the color 
reaction, the membrane was equilibrated for 10 minutes with 20 mL of 0.1 M NaHCO3, 1 
mM MgCl2 at pH=9.8.  Substrate was prepared in the dark, and contained 60 µL of BCIP, 
120 µL of NBT in 0.1 M NaHCO3, 1 mM MgCl2 at pH=9.8. Substrate was added to 
membrane and covered in tinfoil until bands appeared. NOTE: This happened very quickly 
within 5-15 seconds. TE at pH 8 was added to membrane to stop the reaction. 
 
c) S-tag western (used for construct 2): The primary antibody was a 1:1000 (v/v) dilution of 
anti-S-tag antibody produced in rabbit mixed with 1.25% milk powder in TTBS. The 
secondary antibody was a 1:2000 (v/v) dilution of donkey anti-rabbit antibody in TTBS. A 
substrate containing 500 µL of luminol and 500 µL of hydrogen peroxide were mixed in 
the dark. The substrate was pipetted on the membrane and left standing in light for 2 
minutes. The membrane was imaged using a camera capable of chemi-luminescence 
detection.  
2.2.2.10. Dialysis 
     By combining information from UV-vis, gel electrophoresis, and western blot, the fractions 
containing the expressed protein were combined for subsequent dialysis. The combined samples 
were dialyzed using 1000 kDa molecular weight cut-off (MWCO) tubing against 4 L of distilled 
water for 12 hours at 4 °C using gentle stirring.  
2.2.2.11. Lyophilisation  
     The solution was flash-frozen using liquid nitrogen and then freeze dried for 12 hours using a 
Labconco freeze drier (Kansas City, MO, USA).  
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2.2.2.12. Cyanogen Bromide Digest  
   In order to prevent the α-helical SN-fusion protein from influencing the structure of 
FOXL1CTERM/MUT, a CNBr digest was employed to cleave SN off the expressed protein (SN—
FOXL1CTERM—6His or SN—FOXL1MUT—6His). The digestion occurred at a methionine residue 
between the SN and target protein. 1 mL of 70% formic acid was added to the freeze dried sample 
in small glass vial. One crystal of cyanogen bromide (CNBr) that was ~2 mm in diameter was 
carefully added to the sample in the fumehood. The glass vial was capped and wrapped in tinfoil 
for 24 hours (determined by optimization).  
     One experiment performed involved determining the optimal time for CNBr digestion. In this 
case, during the CNBr digest described above, 25 μL aliquots were acquired every 8 hours for a 
total of 3 days, quenched with 500 μL of water, and freeze dried. The solid was dissolved in 60 μL 
of tricine sample buffer, heated for five minutes, and then 40 μL was loaded onto a gel for gel 
electrophoresis. The optimal time was determined to be 24 hours.  
     After CNBr digest, 15 mL of distilled water was then added to quench the reaction. Sample was 
transferred to a 150 mL beaker for lyophilisation (see Section 2.2.2.11). The solid was then 
dissolved in 1 mL of 5 mM imidazole in 6 M urea and TBS, and another Ni affinity column was run 
to separate the SN fusion and target FOXL1CTERM/MUT—6His protein (see Section 2.2.2.6). UV-vis 
(Section 2.2.2.7) and gel electrophoresis (Section 2.2.2.8) was run to determine where the target 
protein eluted. 
2.2.2.13. Size Exclusion Gel Filtration 
     The running buffer (1 L of 0.2% CHAPS, 6 M urea, and TBS) was degassed under vacuum 
filtration using a G6 filter paper. A size exclusion column (S-100, HiPrep 16/60) was equilibrated 
with 2 column volumes of buffer using a flow rate of 0.25 mL/min. A 1.5 mL sample was loaded 
on the column and fractions were eluted using a flow rate of ~0.2 mL/min (unless otherwise 
specified). Size exclusion gel filtration was run until 100 × 1.5 mL fractions were collected. UV-vis 
(Section 2.2.2.7) and gel electrophoresis (Section 2.2.2.8) was run on sample. Fractions containing 
exclusively the target protein were combined, dialyzed against water, freeze dried, and prepared 
for structural determination by circular dichroism.   
 43 
 
2.2.2.14. Circular Dichroism 
     Structural studies were done using circular dichroism which was performed on a Jasco J-810 
spectropolarimeter (Jasco Inc., Easton, MD) in the far ultraviolet range (190-260 nm) with a 0.5 
mm quartz cuvette at room temperature where 20 scans were averaged (unless otherwise 
specified).  
2.2.3. Construct 1: 6His—FOXL1CTERM/MUT  
     A similar transformation protocol as seen in Section 2.2.2.1 was followed to transform the pET-
15b plasmid containing FOXL1CTERM (or FOXL1MUT) with C-terminal 6His into C43(DE3) E. coli cells. 
The cells were cultured in the presence of 35 µg/mL chloramphenicol and 50 µg/mL ampicillin 
antibiotics. The cells were induced to express protein following Section 2.2.2.3 and then lysed 
using the French press procedure seen in Section 2.2.2.4. The cell lysate mixture was centrifuged 
for 30 minutes at 4 °C and the soluble layer was decanted off the pellet. The desired protein was 
assumed to be present in the pellet containing inclusion bodies, and thus was recovered using 6 
M urea in TBS (both with and without 0.5% N-lauroyl sarcosine detergent). The target protein was 
never successfully identified or purified due to low expression yields.   
2.2.4. Construct 2: S-tag—6His—FOXL1CTERM  
     A similar transformation protocol as seen in Section 2.2.2.1 was followed to transform the pET-
29a(+) plasmid containing FOXL1CTERM with N-terminal S- and 6His- tags into BL21(DE)pLysS E. coli 
cells. The cells were cultured in the presence of 35 µg/mL chloramphenicol and 30 µg/mL 
kanamycin antibiotics. The cells were induced to express protein following Section 2.2.2.3 and 
then lysed using the French press procedure seen in Section 2.2.2.4. An S-tag western blot (see 
Section 2.2.2.9) was then run to determine whether the protein was found in (a) the supernatant 
(b) associated with the membrane, or (c) in inclusion bodies sample. Sample was then purified by 
nickel affinity chromatography (Section 2.2.2.6). Dialysis (Section 2.2.2.10) was employed to 
remove unwanted salts and detergents, and samples were concentrated using lyophilisation 
(Section 2.2.2.11). The sample was then prepared for structural studies using circular dichroism 
(Section 2.2.2.14). 
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Chapter 3  
Results 
3.1. Bioinformatics 
      In this section, various bioinformatics programs are employed to predict the disorder, 
sequence alignment, and secondary structure of FOXL1.  
3.1.1. Protein Disorder  
     The ordered and intrinsically disordered regions of FOXL1 was computationally predicted by 
PONDR-FIT as shown in Figure 3.1.  The prediction results of the N-terminal domain are analyzed 
first. From literature, it is known that a structured N-terminal DNA binding domain spans residue 
49-139.14 Although PONDR-FIT does correctly predict an ordered region from residue 52-128, the 
N-terminal domain is underestimated on both ends. This is expected since protein disorder 
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predictors are known to be unreliable along the boundary between the structured and 
intrinsically disordered regions.6 We also note the poor predictive accuracy for short disordered 
regions, as revealed by the two short disordered and one short ordered regions on the N-terminal 
side of the Forkhead domain.  Overall, PONDR-FIT analysis shows good predictive accuracy for the 
N-terminal domain, except close to the boundary between ordered and disordered regions.     
 
Figure 3.1: Prediction of intrinsically disordered regions in the FOXL1 protein using PONDR-FIT.6 
A disorder disposition of 0.5 represents the threshold between the predicted disordered ( >
𝟎. 𝟓) and structured ( < 𝟎. 𝟓) regions. Based on this analysis, a 69 amino acid fragment the spans 
the ordered C-terminal region was investigated. A mutant FOXL1 protein was also studied, 
where a five amino acid (GIPFL) segment was deleted. The predicted ordered regions span 
residue 20-35, 52-128, and 309-345. 
 
     PONDR-FIT predicted that the ordered N-terminal domain is connected by a long intrinsically 
disordered segment (residues 129-308) to an ordered C-terminal region (residues 309-345). This 
prediction suggests that a C-terminal domain exists for FOXL1 that can maintain its structure and 
function independently of the rest of the protein. Since it is both computationally and 
experimentally expensive to study the structure of the full 345 amino acid FOXL1 protein, we 
want to reduce the size of the system studied. Based on this analysis, a 69 amino acid fragment 
was studied (residue 277-345) that completely encompasses the predicted ordered C-terminal 
region and contains a generous portion of the intrinsically disordered domain to account for poor 
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boundary accuracy. From here on, the residues 277-345 will be denoted as FOXL1CTERM and the 
same segment with GIPFL deleted (residues 326-330) will be denoted FOXL1MUT.  
One key insight predicted by PONDR-FIT is that deletion of the GIPFL residues in FOXL1 
occurs in the most ordered portion of the C-terminal domain of FOXL1. This suggests that this 
mutation could severely affect the structure and function of the FOXL1CTERM.   
3.1.2. Sequence Alignment 
     A multiple sequence alignment of FOXL1CTERM with twenty-five FoxL1 proteins (from other 
chordates) was performed by BLASTP, which is illustrated in Figure 3.2. The sequence alignment 
identified a region of similarity spanning residue 30-69 of FOXL1CTERM. In this region, the majority 
of the aligned amino acids are identical or chemically similar. Therefore, this highly conserved 
region of FOXL1CTERM is likely to be structurally or functionally important. In particular, the GIPFL 
residues (50-54) are all identical except phenylalanine (“F”) which is still chemically similar to the 
other amino acids in the alignment. From this information, it is understandable that the deletion 
of GIPFL arising in FOXL1MUT makes the FOXL1 protein malfunction, leading to a human genetic 
disease. Structural changes are also possible considering that five highly conserved amino acids 
are deleted.  
 
Figure 3.2: BLASTP sequence alignment of FOXL1CTERM with 25 other FoxL1 proteins (reference 
UniProt ID: L8ITJ1, S7PCB4, F1S6I8, K7CS34, H2QBP0, D2GWM9, L5JP00, E2QSH5, S9WXI7, 
F1ME43, M1EPZ3, F7I5K2, I3ND78, M3Z8G4, H0XIF7, K7FR74, Q64731, Q8BQE0, G1U009, 
M0R6E1, G3RF46, G1SBX4, H2NRQ1, Q12952, Q498Y4). The GIPFL residues are part of the most 
conserved part of the C-terminal region.  
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     Unfortunately, the proteins that had similar amino acid sequences to FOXL1CTERM did not have 
any published crystal structures. Since a suitable template protein was not available, structural 
information through homology modelling could not be acquired. In lieu of this, secondary 
structure bioinformatics tools were employed to predict FOXL1CTERM structure.  
3.1.3. Secondary Structure Prediction 
The secondary structure of FOXL1 was computationally predicted by PROFsec, a program 
found under the umbrella of the PredictProtein server.33 The entire sequence was submitted to 
PROFsec, which suggested only the N-terminal domain possessed secondary structural elements. 
As shown in Figure 3.3b, PROFsec predicted that the N-terminal domain had four α-helical 
structure as well as two short β-strands. This prediction mostly agreed with the secondary 
structure elements published by Carlsson and Mahlapuu as shown in Figure 3.3a,4 correctly 
predicting three α-helices and two β-strands. However there were a few discrepancies, including 
omitting one small β-strand, incorrectly predicting an α-helix, and both overestimating and 
underestimating the caps of helices and strands. 
The C-terminal domain secondary structure elements were filtered and removed because this 
region had a much lower reliability index attributed to few diverse alignments in comparison to 
the N-terminal domain. In order to force a prediction of the C-terminal region, only the FOXL1CTERM 
sequence was used as input as shown in Figure 3.4b. With the new input sequence, PROFsec 
predicted that FOXL1CTERM had one short α-helix (residue 20-23) and four short β-strands (residue 
34-38, 46-49; 53-56; 65-68). However, the prediction of each of the secondary structural elements 
was not reliable as indicated by a low reliability index scores as shown in Table 3.1. PROFsec 
assigns a structure reliability index score between 0 and 9 for each residue, where “0” means the 
prediction is not reliable while “9” shows high reliability. As seen in Table 3.1, the majority of 
structured residues had a reliability index of 3 or less. FOXL1MUT had a similarly predicted 
secondary structure, as shown in Figure 3.4a, where the major difference was that two β-strands 
had merged into a single β-strand due to the deletion of GIPFL. This prediction also had a low 
reliability index score.  
Structure predictors can potentially be valuable tools to provide insight into protein 
secondary structure. However, in reference to FOXL1, although PROFsec worked fairly well for 
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the N-terminal domain, it did not provide any reliable structural information about the C-terminal 
domain. Since the secondary structure was not reliable for the study of FOXL1CTERM and FOXL1MUT, 
it was not used as a starting structure for subsequent computer simulations. 
 
Figure 3.3: (a) The secondary structure elements of the N-terminal domain of FOXL1 has three 
α-helices spanning residue 54-63, 72-83, and 92-99; three β-strands from residue 68-71, 107-
112, and 120-125; as well as two loops spanning residue 113-119 and 126-140.14 (b) PROFsec 
secondary structure prediction of the entire sequence predicts the C-terminal domain to have 
no secondary structure elements while the N-terminal domain has four α-helical structure 
spanning residue 54-64, 72-82, 97-100, and 128-133, as well as two short β-strands from 
residues 108-109 and 20-125. There are a few discrepancies between the PROFsec predicted 
and published results, including omitting one small β-sheet (residue 68-71), incorrectly 
predicting an α-helix (residue 128-133), and being unreliable along the ends (caps) of helices 
and strands by both overestimating and underestimating the ends. 
 
 
Figure 3.4: PROFsec secondary structure elements prediction of (a) FOXL1MUT and (b) 
FOXL1CTERM. The deletion of GIPFL caused two β-strands FOXL1CTERM (residues from 46-49 and 
53-56) to combine into a single β-strand in FOXL1MUT (residues from “46-57” with 50-54 
removed). 
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Table 3.1: PROFsec prediction of secondary structure for FOXL1CTERM. The prediction for each of 
the secondary structural elements was not reliable as indicated by a low reliability index score.   
Structure Residue 
Number 
Reliability index  
( low = 0 ;  high = 9 ) 
Helix 
21 1 
22 2 
23 1 
25 0 
Extended 
34 2 
35 3 
36 6 
37 5 
38 1 
Extended 
46 2 
47 3 
48 3 
49 1 
Extended 
53 1 
54 1 
55 0 
56 0 
Extended 
65 1 
66 2 
67 2 
68 0 
 
3.2. Computational 
     The tertiary structure of FOXL1CTERM and FOXL1MUT was computationally predicted using 
molecular dynamics (MD) simulations. The PACE force field was combined with replica exchange 
MD (REMD) in order to sample the folded configurational space of these proteins. The generated 
conformations for the 300 K replica were grouped according to the clustering scheme proposed 
by Heyer et. al.55 using a 3 Å RMSD cut-off criteria between aligned Cα atoms.  
3.2.1. FOXL1CTERM 
   Representative FOXL1CTERM structures of the four statistically relevant clusters at 300 K are 
shown in Figure 3.5. These clusters had populations of 14.0%, 7.7%, 3.6%, and 1.6%. The top four 
cluster comprised about 26.9% of the total sampled structures. The other 73.1% of configurations 
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were part of much lower populated clusters or had very similar structures to these top clusters 
but fell outside the 3 Å cut-off. The highest populated structure (14.0%) of FOXL1CTERM had an N-
terminal region that was mostly unstructured and a C-terminal region that had four short β-
strands adjacent to a small α-helix. The GIPFL residues, indicated in red, were located in the core 
of the folded protein. In particular, the phenylalanine (F) sidechain was positioned directly 
towards the interior of the protein, which is to be expected considering phenylalanine is a 
hydrophobic amino acid. The second most populated FOXL1CTERM structure (7.7%) was more 
structured than the first cluster, since it had four N-terminal α-helices and two short C-terminal 
β-strands. Again, the GIPFL residues were found in the core of the folded protein. The third most 
populated structure (3.6%) was similar to the second and had three N-terminal α-helices and two 
short C-terminal β-strands. The glycine and isoleucine of the GIPFL segment formed one of the β-
strands. The GIPFL residues were again in the interior of the folded protein. Finally, the fourth 
most populated FOXL1CTERM structure (1.6%) formed a three-helix bundle with the GIPFL 
sidechains contributing to the hydrophobic core of the domain. The GIPFL sequence was located 
in a helix packed on top of the helix bundle. 
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                             (a) 14.0%                                                                   (b) 7.7% 
  
 
                             (c) 3.6%                                                                      (d) 1.6% 
Figure 3.5: Representative structures of the four most populated clusters for FOXL1CTERM with 
their respective populations indicated below the structures. The population is the percentage 
of the total samples structures from the full 4000 ns simulation that are within a 3 Å RMSD 
criteria of the represented structure. The blue and black spheres mark the N-terminus and C-
terminus, respectively. The GIPFL residues have been indicated in red. 
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3.2.2. FOXL1MUT 
     Figure 3.6 shows representative FOXL1MUT structures of the four largest clusters at 300 K. These 
clusters had populations of 8.7%, 6.8%, 5.0%, and 4.4%. The highest populated structure (8.7%) 
had an N-terminal region with a single α-helix and a C-terminal region with two short β-strands.  
The GIPFL deletion was indicated in red. With the GIPFL residues missing, the surrounding region 
was now solvent exposed on the surface of the protein. The second most populated FOXL1MUT 
structure (6.8%) was less structured than the first, having two N-terminal α-helices and 
disordered C-terminal region. Again, due to the GIPFL deletion, the surrounding region was on 
the exterior on the protein. The third most populated structure (5.0%) was completely 
unstructured except for a small N-terminal α-helix. Finally, the fourth most populated FOXL1CTERM 
structure (4.4%) was similar to the second cluster and had two N-terminal α-helices and 
disordered C-terminal region.  
3.2.3. Comparison 
     The computationally predicted clusters of FOXL1CTERM and FOXL1MUT were completely different. 
First of all, the FOXL1CTERM clusters were more structured and folded than FOXL1MUT. The 
FOXL1CTERM clusters had a significant number of α-helices and β-strands while the mutant 
generally possessed one or two α-helices.  Secondly, the GIPFL residues in FOXL1CTERM are involved 
in structural elements (i.e., a β-strand for the first and third clusters, and an α-helix for the fourth) 
or directly adjacent to structure (i.e. second cluster). In contrast, the FOXL1MUT clusters were 
significantly disordered in the C-terminal region containing the deletion, with the exception of 
the first cluster that has two short β-strands adjacent the deletion. In the FOXL1CTERM clusters, the 
GIPFL residues are located in the hydrophobic core, with the phenylalanine sidechain positioned 
towards the interior of the protein. These computational results suggested that the deletion of 
GIPFL residues in the FOXL1MUT system disrupted the hydrophobic core as well as particular 
structural elements, causing the region adjacent the mutation to become randomly coiled. From 
these results, we hypothesize that the mutation alters the structure of the protein-protein 
binding surface and thereby hinders the C-terminal domain from binding effectively to co-
regulatory protein(s), preventing FOXL1 from carrying out its regulatory functions.   
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                             (a) 8.7%                                                                        (b) 6.8% 
  
 
                             (c) 5.0%                                                                         (d) 4.4% 
Figure 3.6: Representative structures of the four most populated clusters for FOXL1MUT with 
their respective populations indicated below the structures. The population is the percentage 
of the total samples structures from the full 4000 ns simulation that are within a 3 Å RMSD 
criteria of the represented structure. The blue and black spheres marks the N-terminus and C-
terminus, respectively. The location the GIPFL deletion is indicated in red.  
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3.3. Experimental Results 
3.3.1. Introduction 
     This section details the progress made towards expressing, purifying, and structurally 
characterizing FOXL1CTERM/MUT using three different constructs:  (1) 6His—FOXL1CTERM/MUT, (2) S-
tag—6HIS—FOXL1 CTERM, and (3) SN—FOXL1CTERM/MUT—6HIS. The first construct investigated, 6His-
FOXL1CTERM/MUT, had low protein expression and significant sample impurity, which hindered 
identification and purification of the target protein. The second construct studied, S-tag—6HIS—
FOXL1CTERM, also had low protein expression and sample impurities, but allowed for identification 
of the target protein by western blot and enabled structural characterization of an impure target 
protein by circular dichroism. The final construct, SN— FOXL1CTERM/MUT—6HIS, had high expression 
yields, was easily identified via western blot, was successfully enriched, and allowed for some 
structural characterization of the target protein by circular dichroism. The following sections 
discuss the challenges and successes for each construct expression in relevant detail.  
3.3.2. Construct 1: 6His—FOXL1CTERM/MUT 
     The 6His—FOXL1CTERM/MUT construct was expressed six times (four with FOXL1CTERM—6His and 
two with FOXL1MUT—6His) following the protocol in the Methodology section. The desired protein 
was assumed to be present in inclusion bodies based on preliminary data from a co-worker.‡‡ This 
assumption could not be confirmed experimentally due to difficulties in identification and 
purification.   
     Identification and purification of the target protein was complicated due to low protein 
expression and significant sample impurity. This is apparent in Figure 3.7, which shows a silver 
stained gel of FOXL1CTERM—6His (~8.0 kDA) after Ni column purification that contained four major 
protein bands at approximately 8.5, 10, 17, and 24 kDa. This gel required the highly sensitive silver 
staining, which had a detection limit of 1 ng, in order to detect protein bands. In most cases, 
Coomassie staining of a gel, with a detection limit of 100 ng, was not able to detect any protein 
indicating low overall protein expression. Low or unsuccessful protein expression was further 
                                                             
‡‡ Dr. Ahmed Mostafa, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, NL, Canada 
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reinforced by a spotless His-tag western blot, which had a sensitivity range between from 4 ug/mL 
to 1 ng/mL. Apart from a silver stained gel that showed a band with the expected molecular 
weight, the presence of FOXL1 CTERM/MUT was not confirmed by any other method, including MALDI 
(due to high salt or low protein concentration), western blot, and mass spectrometry.  
     Low protein expression can be caused by a number of complex factors. One possible cause is 
that the foreign protein may be toxic to the host strain. If an expressed protein is toxic to the 
host, the proteins may be degraded by the host cell or the host can undergo lysis. Other causes 
for low or no protein expression in a host protein include initiation problems and differences from 
the source organism in environment, chaperones, and codon use bias.88   
     Enrichment of the desired protein was also difficult because the protein eluted early in the Ni 
affinity purification, specifically between 10 – 50 mM of imidazole, and consequently co-eluted 
with at least three other major impurities. Further purification was attempted using HPLC, which 
failed due to insolubility of product in the solvent. Purification using water solubility differences 
was also tried but ineffective because the desired protein and impurities all precipitated in water. 
This last purification attempted was size exclusion gel filtration, which was not effective because 
the protein in eluted fractions were too dilute to detect by UV-vis or silver stain gel 
electrophoresis. The difficult purification and identification of the target protein motivated the 
development of a new protein construct.  
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Figure 3.7: Silver stained 16.5% tris-tricine gel of FOXL1CTERM—6His (~8.0 kDa) following Ni 
column purification using elution scheme 1 in Table 2.1. Four major bands are observed at 8.5 
kDa, 10 kDa, 17 kDa, and 24 kDa that significantly overlap during elution. The protein eluted 
between 10 – 50 mM of imidazole as seen in L.2 – L.6. 
 
 
 
 
 
 
 
 
 57 
 
3.3.3. Construct 2: S-tag—6His—FOXL1CTERM  
     The S-tag—6HIS—FOXL1 CTERM construct was expressed three times using the protocol detailed 
in the Methodology section. In order to determine if the target protein was successfully expressed 
and whether it remained soluble, associated with the membrane, or formed inclusion bodies, a 
gel and S-tagged western blot was run in duplicate on these three crude fractions. As seen in 
Figure 3.8, the Coomassie stained gel did not reveal well-defined protein bands, which is a 
common problem for crude protein mixtures. On the other hand, the western blot showed that 
the majority of S-tagged protein formed inclusion bodies (L.5), while only some associated with 
the cellular membrane (L.4), and very little remained soluble (L.3). Unfortunately, there were two 
S-tagged protein in the inclusion bodies having approximately molecular weights between 8.5-12 
kDa and 12-24 kDa. As demonstrated later in other gels, these two bands fluctuate relative to the 
reference marker, thereby making assignment of the molecular weight difficult. The calculated 
molecular weight of S-tag—6HIS—FOXL1CTERM was 11.2 kDa, and thus it was unclear which of the 
two bands belongs to the target protein. The higher band could not be explained by dimerization 
since this construct did not contain any cysteine residues to form inter-protein disulfide bonds. 
Protein aggregation was also ruled out since the initial gel was run under denaturing (SDS-PAGE) 
conditions. One possibility that accounted for the second S-tagged protein band was that 
transcription started or ended incorrectly resulting in a transcriptional artifact. In contrast to the 
inclusion body fractions, the soluble fraction contained small amounts of only the higher 
molecular weight band. Thus, further investigation was required for the supernatant and the 
inclusion bodies (or combined membrane/ inclusion body) fractions. 
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Figure 3.8: Coomassie stained 16.5% tris-tricine gel (left) and S-tag western blot (right) of the 
crude fractions after cell lysis to determine if the S-tag—6HIS—FOXL1 CTERM (~11.2 kDa) target 
protein remained soluble (L.3), associated with the membrane (L.4), or formed inclusion bodies 
(L.5). An S-tagged protein (L.2) was used as a reference to prove the western blot worked. (Left) 
The Coomassie stained gel showed blurred bands, which is common for crude samples. (Right) 
The western blot revealed two S-tagged proteins present in inclusions bodies and associated 
with the membrane, with the majority of protein in inclusion bodies. These proteins had a 
molecular weight of 8.5-12 kDa and 12-24 kDa as measured by comparison to the marker (L.1.). 
It is unclear which band was the target protein. The soluble fraction appeared to only have a 
single, faint band between 12-24 kDa.    
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3.3.3.1. Inclusion Bodies Sample 
     The crude, solubilized inclusion body sample (L.5 in Figure 3.8) was enriched by first using DE52 
to remove bacterial cell impurities, followed by Ni affinity chromatography using elution scheme 
4 detailed in Table 2.1. Coomassie stained gel and S-tag western blot of the Ni column purification 
is depicted in Figure 3.9. The western blot revealed that two S-tagged proteins with approximate 
molecular weights of 8.5-12 kDa and 12-24 kDa co-eluted at 100 mM of imidazole (L.8). The 
corresponding Coomassie stained gel showed no bands in L.8, signifying that the loaded sample 
had less than 100 ng of protein and, overall, these S-tagged proteins had low expression yields. 
Another gel and S-tag western blot was run on consecutive fractions eluted with 100 mM of 
imidazole as shown in Figure 3.10.  (For reference, L.8 from Figure 3.9 represented the same 
sample as L.6 in Figure 3.10.) The silver stained gel showed that these fractions were impure and 
contained at least three proteins with a molecular weight of 8.5-12 kDa, 12-24 kDa, and 31 kDa. 
The corresponding western blot again revealed two S-tagged proteins between 8.5-12 kDa and 
12-24 kDa. The absorbance of the fractions represented by L.2 to L.10 in Figure 3.10 was less than 
0.003 at 280 nm as measured against a blank containing 100 mM imidazole, 0.2% CHAPS, 6 M 
urea, and TBS. The low absorbance of these fractions, combined with the inability to detect 
protein via Coomassie stain indicated low protein expression.  
     Fractions represented by L.1 to L.5 of Figure 3.10 was prepared for structural determination 
by circular dichroism. The sample was dialyzed against distilled water to remove the salt and 
imidazole, and then freeze dried to yield in 1 mg of white, solid product. The 1 mg of product was 
dissolved in 500 µL of distilled water. The resultant sample had an absorbance of 0.123 at 280 
nm, which equated to approximately 48 µM of protein. The circular dichroism spectrum of this 
sample is shown in Figure 3.11. The CD spectrum exhibited low overall signal-to-noise and 
substantial fluctuations at the lower wavelength - consistent with a lower than ideal protein 
concentration with some small molecular contaminants that scatter at the smaller wavelengths. 
However, even with these shortcomings it was still possible to observe minima at 208 and 222 
nm suggesting an overall α-helical structure. Further enrichment of this sample was not 
attempted due to the very low concentration of protein.  
 
 60 
 
 
Figure 3.9: Coomassie stained 16.5% tris-tricine gel (top) and S-tag western blot (bottom) after 
Ni column purification of the inclusion bodies fraction (see Figure 3.8, L.5) to find S-tag—6HIS—
FOXL1 CTERM (~11.2 kDa). Protein was eluted using elution scheme 4 detailed in Table 2.1. Each 
figure shows a reference marker (L.1), flow-through (L.2), wash (L.3), and select fractions eluted 
using various imidazole concentrations (L.4 – L.10). (Top) Gel did not reveal any bands in L.4-
L.10, suggesting that any protein present was below the detection limit of 100 ng. (Bottom)  
Western blot revealed that two S-tagged proteins, with molecular weights between 8.5-12 kDa 
and 12-24 kDa, co-eluted at 100 mM of imidazole (L.8). 
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Figure 3.10: Silver stained 16.5% tris-tricine gel (top) and S-tag western blot (bottom) after Ni 
column purification of the inclusion bodies fraction showing consecutive fractions eluted using 
100 mM of imidazole to find S-tag—6HIS—FOXL1CTERM (~11.2 kDa). (Top) Gel showed the sample 
was impure, as three protein bands at 8.5-12 kDa, 12-24 kDa, and 31 kDa were present.  
(Bottom) Western blot revealed that two S-tagged proteins, with approximate molecular 
weights between 8.5-12 kDa and 12-24 kDa co-eluted at 100 mM of imidazole. 
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Figure 3.11: Far UV CD spectra of an impure sample of S-tag—6HIS—FOXL1CTERM (~48 µM) in 
distilled water with a 0.5 mm quartz cuvette at room temperature, where 20 scans were 
averaged. The CD spectrum of FOXL1CTERM showed the characteristic features of a predominant 
helical protein revealed by minima at 208 nm and 212 nm.  
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3.3.3.2. Soluble Sample 
     The crude, soluble sample (L.3 in Figure 3.8) was enriched by first using DE52 to remove 
bacterial cell impurities, followed by Ni affinity chromatography using elution scheme 3 detailed 
in Table 2.1. A silver stained gel and S-tag western blot of the Ni column purification is depicted 
in Figure 3.12. The gel showed three protein with approximate weights of 8.5-12, 24-31, and >38 
kDa were present. The corresponding western blot revealed that two S-tagged proteins with 
molecular weights of 8.5-12 and >38 kDa that co-eluted at 50 mM of imidazole (L.2-L.10 on gel).  
     Fractions represented by L.5 to L.10 of Figure 3.12 were prepared for structural determination 
by circular dichroism. The sample was dialyzed against distilled water to remove the salt and 
imidazole, which resulted a white solid precipitating out of solution.  This solid was re-dissolved 
by lowering the pH from 5.6 to 3.2 using HCl, then bringing it back up to a pH of 3.9 using NaOH. 
The absorbance of this sample was 0.311 at 280 nm which equated to 121 µM of protein. The 
circular dichroism spectrum of this sample, shown in Figure 3.13, exhibited minima at 208 and 
222 nm which suggested a dominant helical shape for the protein(s) in solution. Similar to the 
inclusion body sample, it was possible that S-tag—6HIS—FOXL1CTERM had a helical secondary 
structure, but due significant sample impurity this was not confirmed. Purification of this sample 
was not attempted due to low protein concentration.  
     This construct was problematic because of low protein expression and difficulties in identifying 
the target protein due to the presence of two expressed S-tagged proteins. This motivated the 
investigation of a new protein construct. 
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Figure 3.12: Silver stained 16.5% tris-tricine gel (top) and S-tag western blot (bottom) after Ni 
column purification of the soluble fraction showing consecutive fractions eluted using 50 mM 
of imidazole to find S-tag—6HIS—FOXL1CTERM (~11.2 kDa). (Top) Gel showed the sample was 
impure, as three significant protein bands at 8.5-12, 24-31, and >38 kDa were present.  (Bottom)  
Western blot revealed that two S-tagged proteins, with approximate molecular weights 
between 8.5-12 kDa and >38 kDa co-eluted at 50 mM of imidazole. 
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Figure 3.13: Far UV CD spectra of an impure sample of S-tag—6HIS—FOXL1CTERM  (121 µM) in 
distilled water at pH 3.9 with a 0.5 mm quartz cuvette at room temperature, where 5 scans 
were averaged. The CD spectrum showed the characteristic features of a predominant helical 
protein, revealed by minima at 208 nm and 212 nm. 
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3.3.4. Construct 3: SN fusion—FOXL1CTERM/MUT —6His  
     The next construct investigated was designed with an N-terminal SN tag to try and increase 
the protein expression levels as well as a C-terminal 6HIS tag to facilitate purification. The SN—
FOXL1CTERM/MUT—6HIS construct was expressed five times (three times with SN—FOXL1CTERM—
6HIS and twice with SN—FOXL1MUT—6HIS) using the protocol detailed in the Methodology 
section. In order to determine if the target protein remained soluble, associated with the 
membrane, or formed inclusion bodies, Ni affinity column purification was run on each of the 
crude samples for SN—FOXL1CTERM—6HIS and SN—FOXL1MUT—6HIS. In both cases, the target 
protein primarily formed inclusion bodies upon expression. This was illustrated by the 
Coomassie stained gel in Figure 3.14 for SN—FOXL1CTERM—6HIS (~26.0 kDa) and in Figure 3.15 
for SN—FOXL1MUT—6HIS (~25.5 kDa), which showed a very large band at ~26 kDa that was eluted 
with 100 mM imidazole. A western blot probing for the SN moiety confirmed that SN—
FOXL1CTERM—6HIS was successfully expressed in inclusion bodies which is shown in Figure 3.16 
by the large blot at ~26 kDa in L.5-L.10. It was evident that this construct worked significantly 
better than the first two constructs tested due to its (1) significantly higher protein expression 
and (2) the higher imidazole concentration required for target protein elution during Ni affinity 
purification.  
     In order to prevent the α-helical SN-fusion protein from influencing the structure of 
FOXL1CTERM/MUT, a CNBr digest was employed to cleave SN off the expressed protein. To optimize 
the reaction time for CNBr digest, a Coomassie stained gel was run that monitored the CNBr 
digest over time for SN—FOXL1CTERM—6HIS (refer to Section 2.2.2.12 for process details) which 
is shown in Figure 3.17. At time zero (L.2), the expressed protein (SN—FOXL1CTERM—6HIS) 
showed a large band at ~26 kDa. After 16 hours (L.3), the starting protein was partially digested 
into the SN-fusion protein (17.9 kDa) and FOXL1CTERM—6HIS (8.1 kDa). The amount of 
FOXL1CTERM—6HIS protein did not appear to increase after 24 hours (L.4). However, after 40 
hours (L.6), another species resulted that was smaller in size than FOXL1CTERM—6HIS. This 
suggested the CNBr chemical was instead digesting the SN or FOXL1CTERM—6HIS protein. The 
expressed protein was never fully digested, even after 3 days. Thus, the optimal time for CNBr 
digest was between 24-32 hours to obtain about 50% digestion of SN—FOXL1CTERM—6HIS into 
SN-fusion protein and FOXL1CTERM—6HIS. A similar result was observed for the mutant protein.  
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Figure 3.14 UV-vis absorbance (left) and Coomassie stained gel (right) of the fractions following 
Ni affinity column purification to determine if the SN—FOXL1CTERM—6HIS (~26.0 kDa) protein 
remained soluble (top, 12% polyacrylamide tris-glycine gel), associated with the membrane 
(middle, 16.5% tris-tricine gel), or formed inclusion bodies (bottom, 12% polyacrylamide tris-
glycine gel). Elution scheme 3, 8, and 2 detailed in Table 2.1 was employed for Ni column 
chromatography of the top, middle, and bottom experiments, respectively. The Coomassie 
stained gel revealed that significant amounts of protein with the expected molecular weight of 
N—FOXL1CTERM—6HIS expressed as inclusion bodies (L.6-L.9, bottom) and required at least 100 
mM of imidazole for elution. 
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Figure 3.15: UV-vis absorbance (left) and Coomassie stained 16.5% tris-tricine gel (right) of the 
fractions following Ni affinity column purification to determine if the SN—FOXL1MUT—6HIS 
(~25.5 kDa) protein remained soluble (top), associated with the membrane (middle), or formed 
inclusion bodies (bottom). Elution scheme 3, 8, and 2 detailed in Table 2.1 were employed for 
Ni column chromatography of the top, middle, and bottom experiments, respectively. The 
Coomassie stained gel revealed that significant amounts of protein with the expected molecular 
weight of SN—FOXL1MUT—6HIS expressed as inclusion bodies (L.7-L.10) and required at least 
100 mM of imidazole for Ni column elution. 
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Figure 3.16:  Coomassie stained 16.5% tris-tricine gel (top) and SN-tag western blot (bottom) 
after Ni column purification of the inclusion bodies sample to find SN—FOXL1CTERM—6HIS (~26.0 
kDa). Protein was eluted using elusion scheme 2 detailed in Table 2.1. Each figure shows a 
reference ladder (L.1), the sample loaded (L.2), flow-through (L.3), wash (L.4), and select 
fractions eluted using various imidazole concentrations (L.4 – L.10). (Left) The Coomassie 
stained gel revealed that significant amounts of protein with the expected molecular weight of 
SN—FOXL1CTERM—6HIS expressed as inclusion bodies and required at least 100 mM of imidazole 
for Ni column elution. (Right) An SN western blot confirmed that the target protein, with 
approximate molecular weights of 26.0 kDa, eluted at 100 mM of imidazole (L.5-L.10). 
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Figure 3.17: Coomassie stained 16.5% tris-tricine gel showing the CNBr digest of SN—
FOXL1CTERM—6HIS (~26.0 kDa) into SN-tag (17.9 kDa) and FOXL1CTERM—6HIS (~8.5 kDa) over 
three days. The amount of FOXL1CTERM-6HIS protein did not appear to increase after 24 hours 
(L.4). At 40 hours (L.6), another unknown impurity resulted that was smaller in size than 
FOXL1CTERM—6HIS. The optimized CNBr digest time was between 24-32 hours to obtain 50% 
digestion of SN—FOXL1CTERM—6HIS into SN-fusion protein and FOXL1CTERM—6HIS. 
 
3.3.4.1. Sample Purification 
     After CNBr digest, the target proteins (FOXL1CTERM/MUT—6HIS) now possessed at least two other 
impurities including the expressed protein (SN—FOXL1CTERM/MUT—6HIS) and SN-fusion protein. 
Therefore, further purification was required to isolate the target protein. Numerous purification 
protocols were tested to isolate the target protein from the expressed protein and SN-fusion 
protein. These include experiments to separate the proteins based on different Ni binding 
affinities and molecular weights. Overall, the target protein was successfully isolated from the 
SN-fusion protein and the expressed protein using Ni affinity chromatography and size exclusion 
gel filtration, respectively, as discussed below.  
     First of all, since the SN-fusion protein was no longer bound to a His-tag, it was easily removed 
using Ni affinity column purification using elution scheme 2 detailed in Table 2.1. As shown in 
Figure 3.18, the SN-fusion protein eluted in the flow-through (L.3) and wash (L.4), while SN—
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FOXL1CTERM—6HIS and FOXL1CTERM—6HIS remained bound to the Ni column until eluted with 
higher concentrations of imidazole. Unfortunately, L.5 to L.9 revealed that the expressed protein 
and target protein co-eluted at similar concentrations of imidazole. However, the major band of 
the expressed protein (L.6) eluted slightly earlier at 100 mM of imidazole while the major band of 
FOXL1CTERM—6HIS (L.8) eluted later with 200 mM of imidazole.  
      Three purification experiments were attempted to separate the expressed and target protein 
based on their slight Ni binding differences. First, a Ni column was run using a higher loading 
imidazole concentration of 20 mM instead of 5 mM of imidazole as detailed by scheme 5 in Table 
2.1. The idea was that a higher imidazole loading concentration could prevent the initial binding 
of one of the two proteins to the Ni column, such that one protein is removed in the flow-through 
while the other binds to the Ni column.  However, as shown in Figure 3.19, SN—FOXL1CTERM—6HIS 
and FOXL1CTERM—6HIS both were able to bind to the Ni column and again co-eluted between 100-
200 mM of imidazole. The second purification attempt involved using higher volumes of imidazole 
washes, as detailed by scheme 6 in Table 2.1, in order to potentially elute the majority of 
expressed protein before the target protein eluted. As revealed in Figure 3.20, SN—FOXL1MUT—
6HIS and FOXL1MUT—6HIS protein still had significant overlap and co-eluted between 100-200 mM 
of imidazole. A final Ni affinity purification was tried where more incremental imidazole 
concentration washes were employed as shown by scheme 7 in Table 2.1. As revealed in Figure 
3.21, the major band of SN—FOXL1CTERM—6HIS eluted between 80 - 90 mM of imidazole while 
FOXL1CTERM—6HIS eluted at 90 mM imidazole, with significant overlap of the protein. In summary, 
although Ni affinity chromatography successfully separated the target from the SN fusion protein, 
it failed to isolate the target protein from the expressed protein.      
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Figure 3.18: UV-vis absorbance (top) and 16.5% tris-tricine Coomassie stained gel (bottom) of 
the fractions from a second Ni affinity column purification after CNBr digest of SN—
FOXL1CTERM—6HIS. The elution buffer is shown in scheme 2 of Table 2.1. The SN-fusion protein 
eluted in the flow-through (L.3) and wash (L.4), while SN—FOXL1CTERM—6HIS and FOXL1CTERM—
6HIS co-eluted between 100-200 mM of imidazole (L.5 - L.9).  
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Figure 3.19: UV-vis absorbance (top) and Coomassie stained 16.5% tris-tricine gel (bottom) 
following a Ni affinity column purification after CNBr digest of SN—FOXL1CTERM—6HIS. A higher 
initial loading imidazole concentration of 20 mM instead of 5 mM was employed. The elution 
buffer is shown in scheme 5 of Table 2.1. The SN-fusion protein eluted in the flow-through (L.3) 
and wash (L.4), while SN—FOXL1CTERM—6HIS and FOXL1CTERM—6HIS co-eluted between 100-200 
mM of imidazole (L.5 - L.9). A higher imidazole loading concentration did not prevent the initial 
binding of either SN—FOXL1CTERM—6HIS or FOXL1CTERM—6HIS to the Ni column. 
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Figure 3.20: UV-vis absorbance (top) and Coomassie stained 16.5% tris-tricine gel (bottom) of 
the fractions following a Ni affinity column purification after CNBr digest of SN—FOXL1MUT—
6HIS using larger volumes of imidazole washes. The elution buffer is shown in scheme 6 of Table 
2.1. Even with larger volume of the 50 and 100 mM imidazole wash, the SN—FOXL1MUT—6HIS 
and FOXL1MUT—6HIS protein had significant overlap and co-eluted between 100-200 mM of 
imidazole (L.5-L.8). 
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Figure 3.21 UV-vis absorbance (top) and Coomassie stained 16.5% tris-tricine gel (bottom) of 
the fractions following a Ni affinity column purification to separate SN—FOXL1CTERM—6HIS and 
FOXL1CTERM—6HIS. The elution buffer is shown in scheme 7 of Table 2.1. SN—FOXL1CTERM—6HIS 
eluted between 80 - 90 mM of imidazole (L.6 – L.10) while FOXL1CTERM—6HIS eluted at 90 mM 
imidazole (L.8-L.10) with significant overlap of bands. 
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     Two purification experiments that were attempted to separate the expressed and target 
protein based on their different molecular weights were microfiltration and size exclusion gel 
chromatography. First, microfiltration was attempted using a 20 kDa molecular weight cut-off 
(MWCO) Amacon tube to try and separate SN—FOXL1CTERM—6HIS (26.0 kDa) from FOXL1CTERM—
6HIS (8.1 kDa). The objective was that the lower molecular weight FOXL1CTERM—6HIS protein could 
pass through the porous membrane to the filtrate while the higher molecular weight SN—
FOXL1CTERM—6HIS protein would remain in the residue. Figure 3.22 showed that microfiltration 
was not successful because both proteins remained in the residue. It was possible that the urea 
denaturant in the solvent caused the FOXL1CTERM—6HIS protein to become extended (rod 
shaped), giving it the appearance of a larger size, preventing its passage through the porous 
membrane.  
     The second purification tool that was employed to separate the target and expressed protein 
was size exclusion gel filtration (see Section 2.2.2.13 for details). Three size exclusion column 
experiments were run in order to optimize the loading concentration and flow rate. The sample 
preparations are detailed in Table 3.2. In the first experiment, 4 mL of a highly concentrated 
sample containing SN—FOXL1MUT—6HIS and FOXL1MUT—6HIS (No.1 in Table 3.2) was run through 
a size exclusion column at a rate of 0.25 mL/min. As seen in Figure 3.23, the major bands from 
SN—FOXL1MUT—6HIS and FOXL1MUT—6HIS were within 13 mL of each other, which is both the 
observed and predicted result. Thus, a lower loading concentration was required to separate 
these proteins. In the second experiment, 1.5 mL of a more dilute sample of FOXL1MUT—6HIS and 
SN—FOXL1MUT—6HIS (No.2 in Table 3.2) was run through a size exclusion column at a rate of 0.25 
mL/min. As seen in Figure 3.24, size exclusion gel filtration successfully separated the dilute 
sample of FOXL1MUT—6HIS and SN—FOXL1MUT—6HIS into completely independent bands. 
However, the lower concentration made the protein detection by UV-vis impossible and showed 
only very faint bands in the Coomassie stained gel. Purification with these dilute concentrations 
would have unfortunately required numerous size exclusion runs to obtain enough target protein 
for structural studies. Thus, in the final experiment, 1.3 mL of a slightly more concentrated sample 
of FOXL1MUT—6HIS and SN—FOXL1MUT—6HIS (No. 3 in Table 3.2) was run through a size exclusion 
column at a slower rate of 0.15 mL/min. Figure 3.25 revealed that size exclusion gel filtration 
mostly separated a sample of FOXL1MUT—6HIS and SN—FOXL1MUT—6HIS with high recovery of 
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the target protein. Ultimately, although the size exclusion gel filtration purification technique had 
some overlap of target and expressed protein during elution, it was by far the best method tested 
that yielded the largest amounts of enriched target protein. For later reference, a sample 
containing SN—FOXL1CTERM—6HIS and FOXL1CTERM—6HIS was also successfully separated using 
size exclusion gel filtration (No. 4 in Table 3.2) as seen in Figure 3.26. 
 
 
 
Figure 3.22: Coomassie stained 16.5% tris-tricine gel revealed that microfiltration using a 20 
kDa MWCO Amacon tube could not separate FOXL1MUT-6HIS and SN-FOXL1MUT-6HIS protein. L.2, 
L.5, and L.8 represent the sample loaded (representing 5mL of combined fraction 36-48 from 
Figure 3.20); L.3, L.6, and L.9 represent the residue after sample volume was decreased by half; 
and L.4, L.7, and L.10 was the filtrate which contained small amount of both proteins. 
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Table 3.2: Size exclusion column details. 
No. Volume 
Loaded (mL) 
Flow rate 
(mL/min) 
Sample preparation 
1 4.0 0.25 FOXL1MUT—6HIS: Fractions 36-48  (L.6 – L.8 of Figure 3.20) 
from the Ni affinity column filtration was combined and 
concentrated from 12.5 mL to 4 mL using a 5000 Da MWCO 
microfiltration apparatus and then loaded onto size 
exclusion column.  
2 1.5 0.25 FOXL1MUT—6HIS: Sample was fraction 47 (L.6 of Figure 
3.23c) of the first SEC experiment No. 1 
3 1.3 0.15 FOXL1MUT—6HIS: Fractions 48-53 (L.16-L.19 of Figure 3.23d) 
from the first SEC experiment No.1 was concentrated from 
9.5 mL to 1.3 mL using a 5000 Da MWCO microfiltration 
apparatus. 
4 1.5 0.17 FOXL1CTERM—6HIS: Fraction 38-50 (L.8-L.10 of Figure 3.19) 
were dialyzed against water using 1 kDa MWCO tubing, 
freeze dried, dissolved in 1.5 mL of 6 M urea, 0.2% CHAPS, 
TBS. 
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Figure 3.23: Size exclusion column purification to separate FOXL1MUT—6HIS and SN—
FOXL1MUT—6HIS protein done in 6 M urea, 0.2% CHAPS, TBS solvent where 80×1.5mL fractions 
were collected at a rate of 0.25 mL/min (No. 1 in Table 3.2). (a) UV-vis absorbance of the 
collected size exclusion fractions shows one major elution peak centered at fraction 44 with a 
slight shoulder at fraction 61. (b) A plot illustrating the linear relation between the logarithm 
of the molecular weight and the elution volumes for references molecules, shown in blue. The 
range of volumes required to elute FOXL1MUT—6HIS and SN—FOXL1MUT—6HIS are indicated by 
black lines with an orange dot centered on the fraction containing the majority of each protein. 
This plot revealed that the major bands of FOXL1MUT—6HIS and SN—FOXL1MUT—6HIS eluted 
within 13 mL of each other (both predicted and experimentally observed). (c), (d) Coomassie 
stained 16.5% tris-tricine gel of the size exclusion column fractions revealed that FOXL1MUT—
6HIS and SN—FOXL1MUT—6HIS protein elute in many of the same fraction as seen in L.5, L.6, 
and L.12-L.18.  
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Figure 3.24: UV-vis absorbance (top) and Coomassie stained 16.5% tris-tricine gel (bottom) of 
fractions following a size exclusion column purification of a dilute sample containing SN—
FOXL1MUT—6HIS and FOXL1MUT—6HIS (L.2). This was done in 6 M urea, 0.2% CHAPS, TBS solvent 
where 100×1.5mL fractions were collected at a rate of 0.25 mL/min (No. 2 in Table 3.2). UV-vis 
absorbance of the collected fractions did not show any major peaks. Gel of the size exclusion 
column fractions showed faint bands of SN-FOXL1MUT-6HIS protein in fraction 35 and 40 (L.5 and 
L.6) and faint bands representing FOXL1MUT—6HIS in fractions 50 and 55 (L.8 and L.9.) The gel 
revealed that size exclusion gel filtration could successfully separate a dilute sample of SN—
FOXL1MUT—6HIS and FOXL1MUT—6HIS. 
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Figure 3.25: UV-vis absorbance (top) and Coomassie stained 16.5% tris-tricine gel (bottom) of 
fractions following a size exclusion column purification of a sample containing SN—FOXL1MUT—
6HIS and FOXL1MUT—6HIS (L.3). This was done in 6 M urea, 0.2% CHAPS, TBS solvent where 
100×1.5mL fractions were collected at a rate of 0.15 mL/min (No. 3 in Table 3.2). (Top) UV-vis 
absorbance of the collected size exclusion fractions shows a major elution peak centered at 
fraction 43 (L.6) with a slight shoulder at fraction 39 (L.5) as well as a smaller peak centered at 
fraction 62 (L.10). (Bottom) Gel of the size exclusion column fractions showed bands 
representing FOXL1MUT—6HIS protein in fractions 35 to 55 (L.4-L.10) and faint bands of SN—
FOXL1MUT—6HIS in fractions 35-39 (L.4 and L.5). The gel revealed that size exclusion gel filtration 
could successfully separate a sample of SN—FOXL1MUT—6HIS and FOXL1MUT—6HIS with high 
recovery of the target protein.  
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Figure 3.26: UV-vis absorbance (top) and Coomassie stained 16.5% tris-tricine gel (bottom) of 
fractions following a size exclusion column purification of a sample containing SN—
FOXL1CTERM—6HIS and FOXL1CTERM—6HIS (L.2). This was done in 6 M urea, 0.2% CHAPS, TBS 
solvent where 90×1.5mL fractions were collected at a rate of 0.17 mL/min (No. 4 in Table 3.2). 
(Top) UV-vis absorbance of the collected size exclusion fractions shows a major elution peak 
centered at fraction 37 (L.5). (Bottom) Gel of the size exclusion column fractions showed bands 
representing FOXL1CTERM-6HIS protein in fractions 42 to 58 (L.6-L.10) and faint bands of SN—
FOXL1CTERM—6HIS in fractions 33-42 (L.4-L.6) The gel reveals that size exclusion gel filtration can 
successfully separate a sample of FOXL1CTERM-6HIS and SN-FOXL1CTERM-6HIS. 
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3.3.4.2. Structural Analysis 
     After successful enrichment by size exclusion gel filtration, FOXL1CTERM—6HIS and FOXL1MUT—
6HIS were prepared for structural determination by circular dichroism.  
       Two FOXL1MUT—6HIS samples were prepared. The first sample originated from the size 
exclusion column represented by L.7 to L.9 of Figure 3.24. These fractions were combined, 
dialyzed against distilled water, and freeze dried. The remaining solid was dissolved in 300 µL of 
10 mM potassium phosphate at pH 7. CD was run on this sample to yield the spectrum showed 
in the top image of Figure 3.27. This spectrum shows a slight minimum, or perhaps an inflection 
point, around 222 nm and a two-trough minimum at 199 nm and 203 nm. Thus, the protein does 
not appear to be purely α-helical, β-sheet, or random coil in structure. Instead, this CD spectrum 
most likely results from the superposition of at least two types of secondary structure. The 
combination of a random coiled protein spectrum that has negative minima around 200 nm with 
that of a helical protein spectrum which has negative minima at 208 nm and 212 nm could 
potentially reproduce the resultant CD spectrum.  Thus, it was possible that FOXL1MUT—6HIS had 
a randomly coiled structure with some helical regions.  
     The second FOXL1MUT—6HIS sample that was prepared for circular dichroism had originated 
from a size exclusion column represented by L.6 to L.9 of Figure 3.25. These fraction were 
combined, dissolved in 5% acetic acid, dialysed against 2 L of 5% acetic acid, dialyzed against 
distilled water, and then freeze dried. The remaining solid was dissolved in 250 µL of 10 mM 
potassium phosphate at pH 7. CD was run on this sample to yield the spectrum showed in the 
bottom image of Figure 3.27.  This CD spectrum also showed the superimposed features of a 
helical protein (minima at 208 nm and 212 nm) with a random coiled protein (minima around 200 
nm). 
     The FOXL1CTERM—6HIS sample that was prepared for circular dichroism came from the 
combined fractions of a size exclusion column represented by L.7 – L.9 of Figure 3.26. The sample 
was run through a PD-10 desalting column to replace that the salt and imidazole and with 10 mM 
potassium phosphate at pH 7.  The absorbance of this sample was 0.311 at 280 nm which equated 
to 50.6 µM of protein. The circular dichroism spectrum of the eluted sample, shown in Figure 
3.28, exhibited minima at 208 and 222 nm which suggested a dominant helical shape for 
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FOXL1CTERM—6HIS. However, there is significant noise in the spectra and this limits interpretation. 
Consequently, the percentage of α-helical character could not be quantified from the spectra.  
     The final construct, SN—FOXL1CTERM/MUT—6HIS, was the most successful of all constructs 
investigated. First, the expressed protein had high yields and was easily identified via western 
blot. Upon digest to cleave off the SN-fusion protein, a mixture of expressed, SN-fusion, and the 
target protein remained. The target protein was successfully enriched, using Ni affinity 
chromatography to separate out the SN-fusion protein and size exclusion gel filtration to separate 
out the express protein. Finally, circular dichroism of the two proteins yield distinct differences 
between FOXL1CTERM—6HIS and FOXL1MUT—6HIS. While FOXL1CTERM—6HIS gave a predominately 
helical structure, FOXL1MUT—6HIS appeared to have a mixed random coil and helical secondary 
structure.  
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Figure 3.27: Far UV CD spectra of FOXL1MUT—6HIS in 10mM of Potassium phosphate at pH 7.0 
with a 0.5 mm quartz cuvette at room temperature, where 5 scans were averaged, where 
purified fractions were obtained from (top) the second size exclusion column (No. 2 in Table 
3.2) and (bottom) the third size exclusion column (No. 3 in Table 3.2). Both CD spectra showed 
the superposition of a helical protein (minima at 208 nm and 212 nm) with a randomly coiled 
protein (minima between 190-200 nm). 
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Figure 3.28: Far UV CD spectra of FOXL1CTERM—6HIS (50.6 µM) in 10 mM of potassium phosphate 
at pH 7.0 with a 0.5 mm quartz cuvette at room temperature, where 5 scans were averaged. 
The CD spectrum showed the features of a helical protein (minima at 208 nm and 212 nm). 
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3.4. Comparison 
    There is some agreement between the experimental CD spectra and the computationally 
determined structures obtained by clustering analysis, which is depicted in Figure 3.29. For 
FOXL1CTERM, the second, third, and fourth most probable structures show a predominantly helical 
structure that could account for the corresponding CD spectrum. Similarly, for FOXL1MUT, the 
second, third, and fourth most probable structures show a mixed random coil and helical 
structure that could account for the CD spectrum obtained.  
 
 
 
Figure 3.29: Comparison of the experimental CD spectra for FOXL1CTERM and FOXL1MUT. The 
FOXL1MUT spectrum is consistent with a superposition of α-helical and random coiled 
structures, while the FOXL1CTERM is consistent with an α-helical structure. Clusters extracted 
from the REMD simulations that are consistent with the CD results are shown.   
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     Protein structures are increasingly being determined using integrative structural biology 
approaches, where experimental data is combined with computational models. Methods such as 
Modeler, Rosetta, MELD, and molecular dynamics simulations can employ experimental 
parameters as restraints in order to predict a reasonable structure that falls within these 
restraints.89 For example, the structure of the 201 amino acid protein ALG13 was determined by 
combining backbone-only NMR data with Rosetta.90 Currently in this thesis, computational and 
experimental approaches were employed independently of each other in order to determine the 
structure of FOXL1CTERM and FOXL1MUT, making the agreement between preliminary 
computational and experimental data remarkable. To validate these preliminary result, further 
experimental investigation is required. When greater experimental information becomes 
available, such as NMR data, an assessment of the quality of these preliminary results can be 
made.  
     The computational and experimental results both agree that the deletion of GIPFL results in a 
structural change of the C-terminal domain. This is an important result because function-changing 
mutations in proteins do not necessarily change its structure. As a case in point, the protein FOXC1 
may or may not undergo a structural change depending on the mutation.91 FOXC1 is a member 
of the forkhead box family that plays a role in embryonic and ocular (eye) development. Several 
instances of single-point mutations (where one amino acid is replaced by another) have been 
linked to Axenfeld-Rieger (AR) syndrome. AR syndrome is an eye disorder that is characterized by 
irregularities in the front part of the eye, such as a thin and poorly developed iris or abnormalities 
of the cornea. In a study done by Walter and coworkers,91 five single point mutations (P79L, P79T, 
I91S, I91T, and R127H)§§ in FOXC1, which had been identified in patients with AR syndrome, were 
studied in order to observe the effect of these mutations on the structure and function of FOXC1 
protein. The result of this study showed that (1) the I91S and I91T mutation generates local 
structural disruptions, (2) the R127H mutation alters the electrostatic charge of the DNA-binding 
surface, and (3) the P79L and P79T mutation did not significantly change the structure.   
     
                                                             
§§ As an example of the mutation notation, a “P79L” mutation denotes that a “P” (proline) amino acid 
located at residue “79” of the sequence was mutated to a “L” (lysine). 
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Chapter 4  
Conclusion 
4.1. Summary 
     The GIPFL deletion in the C-terminal domain of FOXL1 protein is linked to a human genetic 
disease. The goal of this research was to acquire structural information about FOXL1CTERM and 
FOXL1MUT in order to gain insight into the structural differences that caused improper functioning 
of FOXL1MUT protein. To accomplish this goal, FOXL1CTERM and FOXL1MUT was investigated using: 
(1) bioinformatics techniques to predict structure from amino acid sequence, (2) computational 
simulations to fold these proteins into their native structure through conformational sampling 
techniques, and finally (3) by expressing and structurally characterizing the FOXL1CTERM and 
FOXL1MUT protein.  
      First, bioinformatics was employed to predict the disorder, sequence alignment, and 
secondary structure of FOXL1. The disorder program predicted that a C-terminal domain existed 
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for FOXL1 which prompted investigation of the 69 most C-terminal residues of FOXL1 (FOXL1CTERM) 
and its corresponding mutant containing the GIPFL deletion (FOXL1MUT). One key insight revealed 
through bioinformatics was that the GIPFL deletion occurred in the most ordered and 
evolutionary-conserved portion of the C-terminal domain of FOXL1, suggesting that this mutation 
could severely affect the structure and function of FOXL1CTERM.  Unfortunately, reliable secondary 
structure information was not obtained for FOXL1CTERM due to the absence of homologous protein 
with known structure.  
     Secondly, replica exchange molecular dynamics was employed to predict the most probable 
structures of FOXL1CTERM and FOXL1MUT protein. A variety of possible secondary structures were 
identified for FOXL1CTERM using clustering analysis, including predominantly α-helical structures 
and mixed α-helical/β-sheet structures. Similarly, a variety of possible secondary structures were 
identified for FOXL1MUT, all of which included a disordered C-terminal region. The N-terminal 
region of the FOXL1MUT structures were composed either of α-helical or β-sheet structures. 
Overall, these computationally predicted clusters showed that FOXL1CTERM was more folded and 
structured than FOXL1MUT. These results suggested that the deletion of GIPFL residues in the 
FOXL1MUT system disrupted its structure and hydrophobic core, causing the mutant to become 
predominantly randomly coiled.  
     Interestingly, FOXL1CTERM and FOXL1MUT are the second and third largest proteins folded using 
PACE, which have 69 and 64 amino acids, respectively.24,25,45,53 The largest protein published that 
was correctly folded from a random coil into its native structure using PACE was α3D, a 73 amino 
acid designed protein that forms a three-helix bundle.45,53 As well, FOXL1CTERM and FOXL1MUT are 
the only structures investigated that (potentially) have a significant percentage of intrinsically 
disordered regions. FOXL1CTERM is predicted to be ~47% disordered by PONDR-FIT as seen in Figure 
3.1. FOXL1MUT is even more randomly coiled than FOXL1CTERM based on experimental CD results, 
which is in agreement with the computationally obtained results by comparing the top four 
clusters of the REMD simulations.   
     Finally, progress was made towards expressing, purifying, and structurally characterizing 
FOXL1CTERM and FOXL1MUT protein. This was accomplished using the construct, SN— 
FOXL1CTERM/MUT—6HIS, which had high expression yields, was easily identified via western blot, 
was successfully enriched, and allowed for some structural characterization of the target protein 
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by circular dichroism. The preliminary circular dichroism results suggest that FOXL1CTERM—6HIS 
had a helical structure while FOXL1MUT—6HIS was partially helical with some randomly coiled 
regions.  
     The combination of bioinformatics, computation simulations, and preliminary experimental 
results strongly suggests that the deletion of GIPFL residues in FOXL1MUT negatively affect its 
structure by disrupting the hydrophobic core to yield a more randomly coiled structure. We 
theorize that this disordering in FOXL1MUT may alter the protein-protein binding surface required 
to bind to its co-regulatory protein and thus prevent the mutant FOXL1 protein from functioning 
correctly.  
4.2. Future Work 
4.2.1. Structural Studies 
     The next step in the structural investigation of FOXL1CTERM and FOXL1MUT is to employ NMR to 
elucidate their tertiary structures and identify any disordered regions in these target proteins. 
NMR is an appropriate technique because (1) the disordered regions in these target proteins (as 
indicated by CD and PONDR-FIT) will likely make protein crystallization too difficult for use in X-
ray crystallography,63 (2) EM would not be expected to provide atomic resolution data 
information, and (3) these proteins are too small for EM studies 60 The relatively small molecular 
weights of the target protein (~8.5 kDa) make these proteins suitable for solution NMR studies, 
such as 2D TOCSY and 2D NOESY.80 In many cases, proteins with ambiguous peak assignment 
cannot be determined exclusively from homonuclear 1H NMR data.80 In this case, heteronuclear 
NMR techniques can be explored. This would require developing a procedure for isotopic labelling 
of the protein with 15N or 13C through expression in minimal labelled media.92 In this method, cells 
are first grown in unlabelled rich media and then transferred into a small amount of 15N or 13C 
upon reaching a high cell density for a short growth period.92 Then, the cells are induced to 
produce protein for a short period of time, resulting in isotopically labelled protein.  
     From the acquired homonuclear and heteronuclear NMR data, the solution structures of 
FOXL1CTERM and FOXL1MUT can potentially be determined. These structures can then be refined by 
combining the obtained spatial information with molecular dynamics simulations.76 The atoms 
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with known contacts can be constrained in in the simulation, and then MD can be performed to 
obtain an equilibrated structure.  
4.2.2. Functional Studies 
     The long term goal of this research is to acquire a thorough functional study of FOXL1CTERM and 
FOXL1MUT in order to further understand how this mutation causes a human genetic disease.  
FOXL1CTERM would be studied first in order to (1) determine the co-regulatory protein(s) that can 
bind to the wildtype, (2) identify the key amino acid residues that constitute the binding site, and 
(3) determine the structure and the binding affinities of the resultant protein–FOXL1CTERM 
complexes. Equipped with this information, the mutant protein can be investigated to (4) 
determine if the mutant is also capable of binding the same co-regulatory proteins as the wildtype 
and, if so, (5) investigate the effect of the mutation on the binding sites and binding affinities.  
     In order to perform functional analysis experiments, the wildtype and mutant FOXL1CTERM 
protein must first be expressed and enriched, which can be accomplished using the methodology 
detailed in this thesis. Pull-down assays can then be employed to screen for putative protein 
binding partners of FOXL1CTERM.93 In a pull down assay, the target protein is tagged and captured 
on an immobilized affinity column that binds to the tag. Then, a protein source (e.g. cell lysate) 
that contains potential binding partners is passed through the affinity column. The non-binding 
proteins pass through the column and end up in the flow-through and wash. The bound 
FOXL1CTERM – co-regulatory protein complexes are then eluted from the column using a competing 
analyte. To determine the identity of the co-regulatory proteins, protein band isolation from a 
polyacrylamide gel, tryptic digestion of the isolated protein, and mass spectrometric 
identification of digested peptides can be completed. Once the potential co-regulatory proteins 
have been determined, multidimensional NMR techniques, such as NOESY and 15N-HSQC,65,79 can 
then be employed to identify the key amino acid residues that constitute the binding site of the 
FOXL1CTERM – co-regulatory protein complexes.80 Since the chemical shift of a nucleus in NMR is 
very sensitive to its chemical environment, the binding site and binding interface can often be 
detected from changes in NMR resonance frequencies that occur when the complex is formed.65 
Computer simulations of the protein-protein complexes within the NMR-derived structure can 
also be performed to refine the protein structures and to identify the binding sites and interface. 
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Following this, affinity electrophoresis can used to estimate the binding affinity of the protein-
protein interaction.  
     With respect to the mutant protein, a pull-down assay can also be employed in order to 
determine if the mutant binds to the same co-regulatory proteins as the wildtype.93 If the mutant 
binds to the same co-regulatory proteins then multidimensional NMR experiments, 
computational simulations, and binding energies will also be determined for the potential mutant 
– co-regulatory protein complexes. If the mutant does not bind to the same co-regulatory 
proteins, then this provides a first explanation as to why the mutant FOXL1 protein does not 
function correctly. Equipped with this information, we can attempt to understand the link 
between the mutated FOXL1 protein and the human genetic disease. 
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